{"content":"<li class=\"n-box-item date-title\" data-end=\"1562126399\" data-start=\"1562040000\" data-txt=\"Monday, December 23, 2019\">Tuesday, July  2, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3475567\" data-ts=\"1562103699\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADXS\" target=\"_blank\">ADXS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475567-advaxisminus-6_9-files-for-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Advaxis -6.9% as it files for capital raise</a></h4><ul>   <li>Advaxis (NASDAQ:<a href='https://seekingalpha.com/symbol/ADXS' title='Advaxis, Inc.'>ADXS</a>) is <font color=\"red\">6.9% lower</font> after hours following news that it's <a href=\"https://seekingalpha.com/filing/4555728\" target=\"_blank\">offering shares</a> through Alliance Global Partners.</li>    <li>Buyers will have an option to buy prefunded warrants if buying shares would result in a stake over 4.99%, it says.</li>    <li>It will use proceeds to fund research and development, including investing in ADXS-HOT, investing in ongoing clinical research in ADXS-PSA and ADXS-NEO, and general purposes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475567\" data-linked=\"Advaxis -6.9% as it files for capital raise\" data-tweet=\"$ADXS - Advaxis -6.9% as it files for capital raise https://seekingalpha.com/news/3475567-advaxisminus-6_9-files-for-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3475567-advaxisminus-6_9-files-for-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475565\" data-ts=\"1562103085\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475565-tsla-endp-and-nog-among-notable-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TSLA, ENDP and NOG among notable after hour movers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a> <font color=\"green\">+6.8%</font>. <a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil and Gas, Inc.'>NOG</a> <font color=\"green\">+3.0%</font>. <a href='https://seekingalpha.com/symbol/SALT' title='Scorpio Bulkers Inc.'>SALT</a> <font color=\"green\">+2.9%</font>. <a href='https://seekingalpha.com/symbol/ADXS' title='Advaxis, Inc.'>ADXS</a> <font color=\"green\">+2.1%</font>. <a href='https://seekingalpha.com/symbol/HEAR' title='Turtle Beach Corporation'>HEAR</a> <font color=\"green\">+1.9%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/USNA' title='USANA Health Sciences, Inc.'>USNA</a> <font color=\"red\">-14.6%</font>. <a href='https://seekingalpha.com/symbol/YI' title='111, Inc.'>YI</a> <font color=\"red\">-12.8%</font>. <a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a> <font color=\"red\">-2.9%. </font><a href='https://seekingalpha.com/symbol/ABEV' title='Ambev S.A.'>ABEV</a> <font color=\"red\">-2.1%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475565\" data-linked=\"TSLA, ENDP and NOG among notable after hour movers\" data-tweet=\"$TSLA $NOG $SALT - TSLA, ENDP and NOG among notable after hour movers https://seekingalpha.com/news/3475565-tsla-endp-and-nog-among-notable-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3475565-tsla-endp-and-nog-among-notable-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475552\" data-ts=\"1562101393\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CEI\" target=\"_blank\">CEI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475552-camber-energy-announces-approval-of-1-25-reverse-stock-split-shares-down-18-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Camber Energy announces approval of 1:25 reverse stock split; shares down 18% after hours</a></h4><ul><li>Camber Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/CEI' title='Camber Energy, Inc.'>CEI</a>) <font color=\"red\">down 18%</font> AH as the Board of Directors approved a 1­for­25 reverse split of the Company's issued and outstanding shares of common stock.</li><li>The 1­:25 reverse stock split will be effective pre-market open on Monday, July 8, 2019.</li><li>The reverse stock split is intended to increase the market price per share of Camber's common stock in order to ensure the continued compliance of the Company's common stock with the NYSE continued listing standards.</li><li><a href=\"https://seekingalpha.com/pr/17562230-camber-energy-inc-announces-approval-1-25-reverse-stock-split\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3475552\" data-linked=\"Camber Energy announces approval of 1:25 reverse stock split; shares down 18% after hours\" data-tweet=\"$CEI - Camber Energy announces approval of 1:25 reverse stock split; shares down 18% after hours https://seekingalpha.com/news/3475552-camber-energy-announces-approval-of-1-25-reverse-stock-split-shares-down-18-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3475552-camber-energy-announces-approval-of-1-25-reverse-stock-split-shares-down-18-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475555\" data-ts=\"1562101380\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UMRX\" target=\"_blank\">UMRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475555-unum-down-23-after-hours-on-actr087-clinical-hold\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Unum down 23% after hours on ACTR087 clinical hold</a></h4><ul><li>Thinly traded nano cap Unum Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/UMRX' title='Unum Therapeutics Inc.'>UMRX</a>) slumps <font color=\"red\">23%</font> after hours on light volume in reaction to a <a href=\"https://seekingalpha.com/pr/17562257-unum-therapeutics-announces-regulatory-update-phase-1-trial-actr087\" target=\"_blank\">clinical hold</a> placed by the FDA on its <a href=\"https://clinicaltrials.gov/ct2/show/NCT02776813?lead=unum+therapeutics&amp;phase=0&amp;rank=4\" target=\"_blank\">Phase 1 clinical trial</a> evaluating ACTR087, combined with Roche's Rituxan (rituximab) after lymphodepleting chemo, in patients with relapsed/refractory CD20-positive B cell non-Hodgkin lymphoma.</li><li>The agency instituted the clinical hold, which suspends enrollment as well as treatment of study participants, after one patient experienced serious neurotoxicity and cytomegalovirus &#40;CMV&#41; infection and life-threatening respiratory distress.</li><li>The action should not be fatal to the company considering that it deprioritized it in Q4 2018 in favor of a new construct called ACTR707.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475555\" data-linked=\"Unum down 23% after hours on ACTR087 clinical hold\" data-tweet=\"$UMRX - Unum down 23% after hours on ACTR087 clinical hold https://seekingalpha.com/news/3475555-unum-down-23-after-hours-on-actr087-clinical-hold?source=tweet\" data-url=\"https://seekingalpha.com/news/3475555-unum-down-23-after-hours-on-actr087-clinical-hold\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475527\" data-ts=\"1562099166\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475527-teslaplus-7-after-topping-q2-deliveries-expectations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla +7% after topping Q2 deliveries expectations</a></h4><ul> <li>Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) announces production of 87,048 vehicles in Q2 and deliveries of 95,200 vehicles vs. 87K-91K expected by analysts.</li><li>The deliveries tally included 17,650 Model S/X vehicles and 77,550 Model 3s.</li><li>Tesla says orders generated during the quarter exceeded deliveries to give the EV automaker in the order backlog increase into Q3.</li>   <li>Customer vehicles in transit at the end of Q2 were over 7,400.</li><li>TSLA  <font color=\"green\">+6.90%</font> after hours to  $240.00.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17562231-tesla-q2-2019-vehicle-production-and-deliveries\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3475527\" data-linked=\"Tesla +7% after topping Q2 deliveries expectations\" data-tweet=\"$TSLA - Tesla +7% after topping Q2 deliveries expectations https://seekingalpha.com/news/3475527-teslaplus-7-after-topping-q2-deliveries-expectations?source=tweet\" data-url=\"https://seekingalpha.com/news/3475527-teslaplus-7-after-topping-q2-deliveries-expectations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>910&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475482\" data-ts=\"1562094218\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VZ\" target=\"_blank\">VZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475482-doj-wants-concessions-in-reported-dish-t-mobile-deal-cnbc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DOJ wants more concessions in reported Dish/T-Mobile deal - CNBC</a></h4><ul>   <li>In an update on today's <a href=\"https://seekingalpha.com/news/3475279-t-mobile-dish-agree-divestitures-sprint-merger-cnbc\" target=\"_blank\">reports of a deal firming up</a> between Dish Network (<a href=\"http://seekingalpha.com/symbol/DISH\" target=\"_blank\">DISH</a> <font color=\"green\">+0.3%</font>) and T-Mobile (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color=\"green\">+2%</font>) that could enable the latter's merger with Sprint (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color=\"green\">+4.6%</font>), CNBC's Alex Sherman says the Justice Dept. is <a href=\"https://www.cnbc.com/2019/07/02/doj-pushing-t-mobile-to-give-more-to-dish-sources-say.html\" target=\"_blank\">pushing for a sweeter deal</a> from Deutsche Telekom (<a href=\"http://seekingalpha.com/symbol/DTEGY\" target=\"_blank\">DTEGY</a> <font color=\"green\">+0.1%</font>).</li>    <li>The DOJ is concerned that any deal establish Dish as an effective fourth player in national wireless, along with the combined T-Mobile/Sprint and the top two: Verizon (NYSE:<a href='https://seekingalpha.com/symbol/VZ' title='Verizon Communications Inc.'>VZ</a>) and AT&amp;T (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color=\"green\">+1.1%</font>).</li>    <li>That includes a push to get Dish unlimited access to T-Mobile's network, while T-Mobile is arguing for a limit of 12.5% of capacity.</li>    <li>Dish would have access to the combined network for 6-7 years, after which it would have to move onto a network it built itself, and T-Mobile has pushed for a provision that no strategic investor take more than a 5% stake in Dish, which notably would deter deep pockets like Amazon or Google from helping build out the network.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475482\" data-linked=\"DOJ wants more concessions in reported Dish/T-Mobile deal - CNBC\" data-tweet=\"$VZ $VZ $DISH - DOJ wants more concessions in reported Dish/T-Mobile deal - CNBC https://seekingalpha.com/news/3475482-doj-wants-concessions-in-reported-dish-t-mobile-deal-cnbc?source=tweet\" data-url=\"https://seekingalpha.com/news/3475482-doj-wants-concessions-in-reported-dish-t-mobile-deal-cnbc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>84&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475481\" data-ts=\"1562094095\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475481-microcaps-mostly-among-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps mostly among tech movers</a></h4><ul><li><strong>Gainers: </strong>Maxar Technologies (NYSE:<a href='https://seekingalpha.com/symbol/MAXR' title='Maxar Technologies Inc.'>MAXR</a>) <font color=\"green\">+17%</font>. Digital Ally (NASDAQ:<a href='https://seekingalpha.com/symbol/DGLY' title='Digital Ally, Inc.'>DGLY</a>) <font color=\"green\">+14%</font>. Alithya Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ALYA' title='Alithya Group Inc.'>ALYA</a>) <font color=\"green\">+12%</font>. Pintec Technology Holdings Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/PT' title='Pintec Technology Holdings Limited'>PT</a>) <font color=\"green\">+10%</font>. Internap Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/INAP' title='Internap Corporation'>INAP</a>) <font color=\"green\">+10%</font>.</li> <li><strong>Losers: </strong>CyberOptics (NASDAQ:<a href='https://seekingalpha.com/symbol/CYBE' title='CyberOptics Corporation'>CYBE</a>) <font color=\"red\">-23%</font>. Ceragon Networks (NASDAQ:<a href='https://seekingalpha.com/symbol/CRNT' title='Ceragon Networks Ltd.'>CRNT</a>) <font color=\"red\">-10%</font>. Materialise NV (NASDAQ:<a href='https://seekingalpha.com/symbol/MTLS' title='Materialise NV'>MTLS</a>) <font color=\"red\">-9%</font>. Phunware (NASDAQ:<a href='https://seekingalpha.com/symbol/PHUN' title='Phunware, Inc.'>PHUN</a>) <font color=\"red\">-9%</font>. Optical Cable (NASDAQ:<a href='https://seekingalpha.com/symbol/OCC' title='Optical Cable Corporation'>OCC</a>) <font color=\"red\">-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475481\" data-linked=\"Microcaps mostly among tech movers\" data-tweet=\"$MAXR $DGLY $ALYA - Microcaps mostly among tech movers https://seekingalpha.com/news/3475481-microcaps-mostly-among-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3475481-microcaps-mostly-among-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475461\" data-ts=\"1562091594\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KIMTF\" target=\"_blank\">KIMTF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475461-kia-motors-america-announces-june-sales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kia Motors America announces June sales</a></h4><ul><li>Kia Motors America (<a href='https://seekingalpha.com/symbol/KIMTF' title='Kia Motors Corp.'>OTCPK:KIMTF</a>) units sales rose <a href=\"https://seekingalpha.com/pr/17562033-kia-motors-america-announces-june-sales\" sasource=\"qp_sum_news_1\" target=\"_blank\">0.4%</a> to 56,801 in June.</li><li>The sales were led by 28.6% rise in Optima model.</li><li>YTD Kia sales expanded 3.8% to 304,844 units.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475461\" data-linked=\"Kia Motors America announces June sales\" data-tweet=\"$KIMTF - Kia Motors America announces June sales https://seekingalpha.com/news/3475461-kia-motors-america-announces-june-sales?source=tweet\" data-url=\"https://seekingalpha.com/news/3475461-kia-motors-america-announces-june-sales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475456\" data-ts=\"1562091422\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475456-waymo-robotaxis-get-california-approval\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Waymo robotaxis get California approval</a></h4><ul><li>California regulators have given Waymo (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet Inc.'>GOOG</a> <font color='green'>+0.6%</font>)(<a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet Inc.'>GOOGL</a> <font color='green'>+0.6%</font>) permission to transport passengers in its self-driving taxis, according to <a href=\"https://techcrunch.com/2019/07/02/waymo-is-now-allowed-to-transport-passengers-in-its-self-driving-vehicles-on-california-roads/?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+Techcrunch+%28TechCrunch%29\" target=\"_blank\"><em>TechCrunch</em></a>.</li><li>Waymo confirms the permit approval to participate in the state's Autonomous Vehicle Passenger Service pilot. Under the program's terms, Waymo can't charge for rides, must have a safety driver behind the wheel, and needs to report passenger miles traveled and safety protocols to state regulators.</li><li>Waymo employees and their guests traveling in the South Bay area will be the robotaxi test riders.</li><li>Note that this approval and pilot program is separate from the state DMV permits given to Waymo, Apple, and others to test self-driving vehicles on California's roads.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475456\" data-linked=\"Waymo robotaxis get California approval\" data-tweet=\"$GOOG $GOOGL - Waymo robotaxis get California approval https://seekingalpha.com/news/3475456-waymo-robotaxis-get-california-approval?source=tweet\" data-url=\"https://seekingalpha.com/news/3475456-waymo-robotaxis-get-california-approval\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>68&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475444\" data-ts=\"1562091276\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMWYY\" target=\"_blank\">BMWYY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475444-bmw-brand-u-s-sales-up-7_5-in-june\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BMW brand U.S. sales up 7.5% in June</a></h4><ul> <li>BMW (<a href='https://seekingalpha.com/symbol/BMWYY' title='Bayerische Motoren Werke Aktiengesellschaft'>OTCPK:BMWYY</a>) brand unit sales <a href=\"https://seekingalpha.com/pr/17562065-bmw-north-america-reports-june-2019-u-s-sales\" sasource=\"qp_sum_news_42\" target=\"_blank\">+7.5%</a> to 31,627 units.</li><li>BMW passenger car sales dropped 11.8% during the month to 16,854 units.</li><li>BMW light truck sales were up 43.4% to 14,773 units during the month.</li><li>YTD BMW brand sales increased 2% to 156,440 units.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475444\" data-linked=\"BMW brand U.S. sales up 7.5% in June\" data-tweet=\"$BMWYY - BMW brand U.S. sales up 7.5% in June https://seekingalpha.com/news/3475444-bmw-brand-u-s-sales-up-7_5-in-june?source=tweet\" data-url=\"https://seekingalpha.com/news/3475444-bmw-brand-u-s-sales-up-7_5-in-june\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475439\" data-ts=\"1562090883\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FUJHY\" target=\"_blank\">FUJHY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475439-subaru-u-s-sales-rose-2_8-in-june\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Subaru U.S. sales rose 2.8% in June</a></h4><ul> <li>Subaru (<a href='https://seekingalpha.com/symbol/FUJHY' title='Subaru Corporation'>OTCPK:FUJHY</a>) unit sales <a href=\"https://seekingalpha.com/pr/17562035-subaru-america-inc-reports-best-ever-june-sales-record-first-half-results\" sasource=\"qp_sum_news_3\" target=\"_blank\">+2.8%</a> to 61,511 units in June.</li><li>Sales growth by model: Ascent +269.7% to 7,014 unit; Forester +5.7% to 14,753 unit; Outback +8.9% to 17,505; Crosstrek -20.7% to 11,392.</li><li>YTD Subaru U.S. sales grew 5.2% to 339,525 units.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475439\" data-linked=\"Subaru U.S. sales rose 2.8% in June\" data-tweet=\"$FUJHY $FUJHF - Subaru U.S. sales rose 2.8% in June https://seekingalpha.com/news/3475439-subaru-u-s-sales-rose-2_8-in-june?source=tweet\" data-url=\"https://seekingalpha.com/news/3475439-subaru-u-s-sales-rose-2_8-in-june\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475427\" data-ts=\"1562090506\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475427-eldorado-gold-and-harmony-gold-mining-among-energy-materials-gainers-seadrill-and-unit-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eldorado Gold and Harmony Gold Mining among Energy/Materials gainers; Seadrill and Unit among losers</a></h4><ul><li><b>Gainers: </b>Eldorado Gold (NYSE:<a href='https://seekingalpha.com/symbol/EGO' title='Eldorado Gold Corporation'>EGO</a>) <font color=\"green\">+7%</font>. Harmony Gold Mining (NYSE:<a href='https://seekingalpha.com/symbol/HMY' title='Harmony Gold Mining Company Limited'>HMY</a>) <font color=\"green\">+7%</font>. Earthstone Energy (NYSE:<a href='https://seekingalpha.com/symbol/ESTE' title='Earthstone Energy, Inc.'>ESTE</a>) <font color=\"green\">+6%</font>. Key Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a>) <font color=\"green\">+6%</font>. First Majestic Silver (NYSE:<a href='https://seekingalpha.com/symbol/AG' title='First Majestic Silver Corp.'>AG</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Seadrill (NYSE:<a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited'>SDRL</a>) <font color=\"red\">-9%</font>. Unit (NYSE:<a href='https://seekingalpha.com/symbol/UNT' title='Unit Corporation'>UNT</a>) <font color=\"red\">-8%</font>. Covia (NYSE:<a href='https://seekingalpha.com/symbol/CVIA' title='Covia Holdings Corporation'>CVIA</a>) <font color=\"red\">-8%</font>. HighPoint Resources (NYSE:<a href='https://seekingalpha.com/symbol/HPR' title='HighPoint Resources Corporation'>HPR</a>) <font color=\"red\">-8%</font>. Chemours (NYSE:<a href='https://seekingalpha.com/symbol/CC' title='The Chemours Company'>CC</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475427\" data-linked=\"Eldorado Gold and Harmony Gold Mining among Energy/Materials gainers; Seadrill and Unit among losers\" data-tweet=\"$EGO $HMY $ESTE - Eldorado Gold and Harmony Gold Mining among Energy/Materials gainers; Seadrill and Unit among losers https://seekingalpha.com/news/3475427-eldorado-gold-and-harmony-gold-mining-among-energy-materials-gainers-seadrill-and-unit-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3475427-eldorado-gold-and-harmony-gold-mining-among-energy-materials-gainers-seadrill-and-unit-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475425\" data-ts=\"1562090449\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HMC\" target=\"_blank\">HMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475425-american-honda-sales-down-7_3-in-june\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Honda sales down 7.3% in June</a></h4><ul><li>Honda (<a href='https://seekingalpha.com/symbol/HMC' title='Honda Motor Co., Ltd.'>HMC</a>) unit sales <a href=\"https://seekingalpha.com/pr/17562053-american-honda-announces-june-sales-results\" sasource=\"qp_sum_news_8\" target=\"_blank\">-7.3%</a> to 135,901 units vs. -6.7% forecast by Edmunds.</li><li>Sales decreased 9.1% for cars and 5.7% for trucks.</li><li>Sales in the Honda division declined 6.3% to 123,753 units and Acura sales fell 16.4% to 12,148 units.</li><li>Civic sales slipped 5.1% and Accord down 18.1% for the month.</li><li>YTD Honda sales slide 1.4% to 776,995 units.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475425\" data-linked=\"American Honda sales down 7.3% in June\" data-tweet=\"$HMC $HNDAF - American Honda sales down 7.3% in June https://seekingalpha.com/news/3475425-american-honda-sales-down-7_3-in-june?source=tweet\" data-url=\"https://seekingalpha.com/news/3475425-american-honda-sales-down-7_3-in-june\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475415\" data-ts=\"1562089659\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KEYS\" target=\"_blank\">KEYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475415-keysight-appoints-general-counsel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Keysight appoints general counsel</a></h4><ul><li>Keysight (<a href='https://seekingalpha.com/symbol/KEYS' title='Keysight Technologies, Inc.'>KEYS</a> <font color='red'>-2.3%</font>) <a href=\"https://seekingalpha.com/pr/17562025-keysight-technologies-appoints-jeffrey-li-senior-vice-president-general-counsel-secretary\" target=\"_blank\">appoints</a> Jeffrey Li as SVP, general counsel, and board secretary.</li><li>Li served as the assistant general counsel and secretary since 2013 and took on the acting general counsel role in February of this year.</li><li>Li's prior work history includes positions at Agilent Technologies and Openwave Systems.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475415\" data-linked=\"Keysight appoints general counsel\" data-tweet=\"$KEYS - Keysight appoints general counsel https://seekingalpha.com/news/3475415-keysight-appoints-general-counsel?source=tweet\" data-url=\"https://seekingalpha.com/news/3475415-keysight-appoints-general-counsel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475401\" data-ts=\"1562088303\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MPW\" target=\"_blank\">MPW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475401-medical-properties-up-4-on-bullish-suntrust-call\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medical Properties up 4% on bullish SunTrust call</a></h4><ul><li>Citing the potential for Medical Properties Trust (<a href='https://seekingalpha.com/symbol/MPW' title='Medical Properties Trust, Inc.'>MPW</a> <font color=\"green\">+3.6%</font>) to capitalize on its \"large acquisition pipeline,\" SunTrust's Michael Lewis upgrades the stock to Buy with a $20 (11% upside) price target.</li><li>Mr. Lewis likes the upside from domestic deals considering the lower valuations.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475401\" data-linked=\"Medical Properties up 4% on bullish SunTrust call\" data-tweet=\"$MPW - Medical Properties up 4% on bullish SunTrust call https://seekingalpha.com/news/3475401-medical-properties-up-4-on-bullish-suntrust-call?source=tweet\" data-url=\"https://seekingalpha.com/news/3475401-medical-properties-up-4-on-bullish-suntrust-call\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>50&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475395\" data-ts=\"1562088157\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BSET\" target=\"_blank\">BSET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475395-bassett-furniture-down-11-post-q2-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bassett Furniture down 11% post Q2 earnings miss</a></h4><ul><li>Bassett Furniture (<a href='https://seekingalpha.com/symbol/BSET' title='Bassett Furniture Industries, Incorporated'>BSET</a> <font color=\"red\">-11.7%</font>) reported Q2 sales of $108.2M, a decline of 7.5% Y/Y; comparable store sales fell 14.8%.</li><li>Wholesale segment sales were $63.1M a decrease of 1% Y/Y, due a 7% decrease in furniture shipments to the open market.</li><li>Retail segment sales were $62.6M a decrease of 8.9% Y/Y, due 14.8% decrease in sales for the 59 comparable stores.</li><li>Logistical services segment revenue was $20.1M a decrease of 5.4% Y/Y, due to the previously announced discontinuation of home delivery services to third-party customers.</li><li>Q2 Operating margin <font color=\"red\">declined by 420 bps</font> to 0.6%.</li><li>Net cash used in operating activities YTD was $8.94M, compared to cash provided $279k a year ago.</li><li>Store count YTD increased to 103, as compared to 97 as on November, 2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3475323-bassett-furniture-eps-misses-0_19-misses-revenue\" target=\"_blank\">Bassett Furniture EPS misses by $0.19, misses on revenue</a> (July 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3475395\" data-linked=\"Bassett Furniture down 11% post Q2 earnings miss\" data-tweet=\"$BSET - Bassett Furniture down 11% post Q2 earnings miss https://seekingalpha.com/news/3475395-bassett-furniture-down-11-post-q2-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3475395-bassett-furniture-down-11-post-q2-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475386\" data-ts=\"1562087022\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475386-nuverra-environmental-solutions-and-aqua-metals-among-industrial-gainers-belden-and-american\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nuverra Environmental Solutions and Aqua Metals among industrial gainers; Belden and  American Superconductor among losers</a></h4><ul><li><b>Gainers: </b>Orion Group Holdings (NYSE:<a href='https://seekingalpha.com/symbol/ORN' title='Orion Group Holdings, Inc.'>ORN</a>) <font color=\"green\">+13%</font>. ReTo Eco-Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/RETO' title='ReTo Eco-Solutions, Inc.'>RETO</a>) <font color=\"green\">+13%</font>. Aqua Metals (NASDAQ:<a href='https://seekingalpha.com/symbol/AQMS' title='Aqua Metals, Inc.'>AQMS</a>) <font color=\"green\">+12%</font>. Nuverra Environmental Solutions (NYSEMKT:<a href='https://seekingalpha.com/symbol/NES' title='Nuverra Environmental Solutions, Inc.'>NES</a>) <font color=\"green\">+11%</font>. The New Home Company (NYSE:<a href='https://seekingalpha.com/symbol/NWHM' title='The New Home Company Inc.'>NWHM</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>Select Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/WTTR' title='Select Energy Services, Inc.'>WTTR</a>) <font color=\"red\">-10%</font>. Intelligent Systems (NYSEMKT:<a href='https://seekingalpha.com/symbol/INS' title='Intelligent Systems Corporation'>INS</a>) <font color=\"red\">-6%</font>. Belden (NYSE:<a href='https://seekingalpha.com/symbol/BDC' title='Belden Inc.'>BDC</a>) <font color=\"red\">-6%</font>. American Superconductor (NASDAQ:<a href='https://seekingalpha.com/symbol/AMSC' title='American Superconductor Corporation'>AMSC</a>) <font color=\"red\">-6%</font>. Hebron Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/HEBT' title='Hebron Technology Co., Ltd.'>HEBT</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475386\" data-linked=\"Nuverra Environmental Solutions and Aqua Metals among industrial gainers; Belden and  American Superconductor among losers\" data-tweet=\"$ORN $RETO $AQMS - Nuverra Environmental Solutions and Aqua Metals among industrial gainers; Belden and American Superconductor among losers https://seekingalpha.com/news/3475386-nuverra-environmental-solutions-and-aqua-metals-among-industrial-gainers-belden-and-american?source=tweet\" data-url=\"https://seekingalpha.com/news/3475386-nuverra-environmental-solutions-and-aqua-metals-among-industrial-gainers-belden-and-american\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475383\" data-ts=\"1562086592\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475383-mdjm-leads-financial-gainers-puyi-and-lendingtree-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MDJM leads financial gainers, Puyi and LendingTree among losers</a></h4><ul><li><b>Gainers:</b> MDJM (NASDAQ:<a href='https://seekingalpha.com/symbol/MDJH' title='MDJM Ltd.'>MDJH</a>) <font color=\"green\">+44%</font>. Loop Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/LOOP' title='Loop Industries, Inc.'>LOOP</a>) <font color=\"green\">+7%</font>. Oxbridge Re Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/OXBR' title='Oxbridge Re Holdings Limited'>OXBR</a>) <font color=\"green\">+6%</font></li><li><b>Losers:</b> Puyi (NASDAQ:<a href='https://seekingalpha.com/symbol/PUYI' title='Puyi Inc.'>PUYI</a>) <font color=\"red\">-21%</font>. Medallion Financial (NASDAQ:<a href='https://seekingalpha.com/symbol/MFIN' title='Medallion Financial'>MFIN</a>) <font color=\"red\">-5%</font>. LendingTree (NASDAQ:<a href='https://seekingalpha.com/symbol/TREE' title='LendingTree, Inc.'>TREE</a>) <font color=\"red\">-5%</font>. China Internet Nationwide Financial Services (NASDAQ:<a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475383\" data-linked=\"MDJM leads financial gainers, Puyi and LendingTree among losers\" data-tweet=\"$MDJH $LOOP $OXBR - MDJM leads financial gainers, Puyi and LendingTree among losers https://seekingalpha.com/news/3475383-mdjm-leads-financial-gainers-puyi-and-lendingtree-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3475383-mdjm-leads-financial-gainers-puyi-and-lendingtree-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475376\" data-ts=\"1562086204\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLD\" target=\"_blank\">GLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475376-gold-and-bonds-perky-vp-reportedly-recalled-from-new-hampshire\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold and bonds perky as VP reportedly recalled from New Hampshire</a></h4><ul><li>Vice President Mike Pence has canceled a New Hampshire appearance to return to the White House, say sources.</li><li>No reason is apparent, but earlier today 14 sailors were reported dead after a fire broke out on a Russian sub.</li><li>Gold (<a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a> <font color=\"green\">+1.6%</font>) has popped back over $1,400, and the 10-year Treasury yield is off five basis points to 1.97%. <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a> <font color=\"green\">+0.7%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a> <font color=\"red\">-1.4%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475376\" data-linked=\"Gold and bonds perky as VP reportedly recalled from New Hampshire\" data-tweet=\"$GLD $TLT $TBT - Gold and bonds perky as VP reportedly recalled from New Hampshire https://seekingalpha.com/news/3475376-gold-and-bonds-perky-vp-reportedly-recalled-from-new-hampshire?source=tweet\" data-url=\"https://seekingalpha.com/news/3475376-gold-and-bonds-perky-vp-reportedly-recalled-from-new-hampshire\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>77&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475374\" data-ts=\"1562086039\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475374-microcaps-mostly-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps mostly among midday movers</a></h4><ul><li><strong>Gainers: </strong>MDJM (NASDAQ:<a href='https://seekingalpha.com/symbol/MDJH' title='MDJM Ltd.'>MDJH</a>) <font color=\"green\">+48%</font>. Oasmia Pharmaceutical AB (NASDAQ:<a href='https://seekingalpha.com/symbol/OASM' title='Oasmia Pharmaceutical AB &#40;publ&#41;'>OASM</a>) <font color=\"green\">+27%</font>. Xcel Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/XELB' title='Xcel Brands, Inc.'>XELB</a>) <font color=\"green\">+20%</font>. Alithya Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ALYA' title='Alithya Group Inc.'>ALYA</a>) <font color=\"green\">+17%</font>. Maxar Technologies (NYSE:<a href='https://seekingalpha.com/symbol/MAXR' title='Maxar Technologies Inc.'>MAXR</a>) <font color=\"green\">+16%</font>. Amarin Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRN' title='Amarin Corporation plc'>AMRN</a>) <font color=\"green\">+13%</font>. ReTo Eco-Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/RETO' title='ReTo Eco-Solutions, Inc.'>RETO</a>) <font color=\"green\">+13%</font>. Orion Group Holdings (NYSE:<a href='https://seekingalpha.com/symbol/ORN' title='Orion Group Holdings, Inc.'>ORN</a>) <font color=\"green\">+13%</font>. Corvus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CRVS' title='Corvus Pharmaceuticals, Inc.'>CRVS</a>) <font color=\"green\">+12%</font>. Aqua Metals (NASDAQ:<a href='https://seekingalpha.com/symbol/AQMS' title='Aqua Metals, Inc.'>AQMS</a>) <font color=\"green\">+12%</font>.</li> <li><strong>Losers: </strong>CyberOptics Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/CYBE' title='CyberOptics Corporation'>CYBE</a>) <font color=\"red\">-22%</font>. Puyi (NASDAQ:<a href='https://seekingalpha.com/symbol/PUYI' title='Puyi Inc.'>PUYI</a>) <font color=\"red\">-23%</font>. OncoCyte Corporation (NYSEMKT:<a href='https://seekingalpha.com/symbol/OCX' title='OncoCyte Corporation'>OCX</a>) <font color=\"red\">-21%</font>. Rafael Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/RFL' title='Rafael Holdings, Inc.'>RFL</a>) <font color=\"red\">-16%</font>. Xenetic Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/XBIO' title='Xenetic Biosciences, Inc.'>XBIO</a>) <font color=\"red\">-13%</font>. Bassett Furniture Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/BSET' title='Bassett Furniture Industries, Incorporated'>BSET</a>) <font color=\"red\">-11%</font>. Evofem Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/EVFM' title='Evofem Biosciences, Inc.'>EVFM</a>) <font color=\"red\">-11%</font>. The Alkaline Water Company (NASDAQ:<a href='https://seekingalpha.com/symbol/WTER' title='The Alkaline Water Company Inc.'>WTER</a>) <font color=\"red\">-10%</font>. JMU Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/JMU' title='JMU Limited'>JMU</a>) <font color=\"red\">-11%</font>. Atreca (NASDAQ:<a href='https://seekingalpha.com/symbol/BCEL' title='Atreca, Inc.'>BCEL</a>) <font color=\"red\">-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475374\" data-linked=\"Microcaps mostly among midday movers\" data-tweet=\"$MDJH $OASM $XELB - Microcaps mostly among midday movers https://seekingalpha.com/news/3475374-microcaps-mostly-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3475374-microcaps-mostly-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475369\" data-ts=\"1562085827\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/POAHY\" target=\"_blank\">POAHY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475369-porsche-reports-record-u-s-retail-sales-in-june\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Porsche reports record U.S. retail sales in June</a></h4><ul><li>Porsche (<a href='https://seekingalpha.com/symbol/POAHY' title='Porsche Automobil Holding SE'>OTCPK:POAHY</a>) unit sales rose <a href=\"https://seekingalpha.com/pr/17562002-porsche-reports-record-u-s-retail-sales-june\" sasource=\"qp_sum_news_1\" target=\"_blank\">6.4%</a> to 5,205 units in June.</li><li>911 sales slipped 39.3% to 458 units.</li><li>718 sales down 25.3% to 422 units</li><li>Cayenne sales advanced 101.9% to 1,147 units.</li><li>Panamera sales dropped 28% to 529 units.</li><li>Macan sales grew 16.7% to 2,649 units.</li><li>YTD Porsche U.S. sales +2.8% to 30,257 units.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475369\" data-linked=\"Porsche reports record U.S. retail sales in June\" data-tweet=\"$POAHY $POAHF - Porsche reports record U.S. retail sales in June https://seekingalpha.com/news/3475369-porsche-reports-record-u-s-retail-sales-in-june?source=tweet\" data-url=\"https://seekingalpha.com/news/3475369-porsche-reports-record-u-s-retail-sales-in-june\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475368\" data-ts=\"1562085416\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475368-nvidias-super-gaming-gpus-racing-amd\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nvidia&#39;s Super gaming GPUs racing AMD</a></h4><ul><li>Nvidia (<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a> <font color='red'>-1.9%</font>) <a href=\"https://seekingalpha.com/pr/17561727-great-power-comes-great-gaming-nvidia-launches-geforce-rtx-super-series\" target=\"_blank\">will launch</a> the GeForce RTX 2060 Super and RTX 2070 Super cards on July 9 and the RTX 2080 Super on July 23.</li><li>The Turing-based cards will retail for $399, $499, and $699, respectively.</li><li>Nvdia says the 2080 Super offers faster performance than its current top-of-the-line Titan Xp.</li><li>Last month, rival AMD (<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color='red'>-0.6%</font>) unveiled its Radeon RX 5000-series gaming chipsets with the \"best of the best\" Radeon 5700 XT priced at $499 with a July release.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475368\" data-linked=\"Nvidia&#39;s Super gaming GPUs racing AMD\" data-tweet=\"$NVDA $NVDA $AMD - Nvidia&#39;s Super gaming GPUs racing AMD https://seekingalpha.com/news/3475368-nvidias-super-gaming-gpus-racing-amd?source=tweet\" data-url=\"https://seekingalpha.com/news/3475368-nvidias-super-gaming-gpus-racing-amd\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>153&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475367\" data-ts=\"1562085414\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VLKPF\" target=\"_blank\">VLKPF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475367-volkswagen-u-s-sales-rises-10-in-june\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Volkswagen U.S. sales rises 10% in June</a></h4><ul><li>Volkswagen (<a href='https://seekingalpha.com/symbol/VLKPF' title='Volkswagen AG Preferred Stock'>OTC:VLKPF</a>) unit sales <a href=\"https://media.vw.com/en-us/releases/1107\" sasource=\"qp_sum_news_1\" target=\"_blank\">+10%</a> to 31,725 units vs. -3.2% forecast from Edmunds.</li><li>Golf sales up 3% to 3,656 units.</li><li>Jetta sales up 17% to 8,486 units.</li><li>Total Beetle sales rose 50% to 1,686 units.</li><li>Passat sales squeezed 79% to 797 units.</li><li>Tiguan sales increased 19% to 9,250 units.</li><li>Atlas sales grew 101% to 7,424 units.</li><li>CPO sales expanded 13% to 9,780 units</li><li>YTD Volkswagen U.S. sales +6.8% to 184,608 units.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475367\" data-linked=\"Volkswagen U.S. sales rises 10% in June\" data-tweet=\"$VLKPF $VLKAF $VWAGY - Volkswagen U.S. sales rises 10% in June https://seekingalpha.com/news/3475367-volkswagen-u-s-sales-rises-10-in-june?source=tweet\" data-url=\"https://seekingalpha.com/news/3475367-volkswagen-u-s-sales-rises-10-in-june\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475364\" data-ts=\"1562085279\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WTER\" target=\"_blank\">WTER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475364-alkaline-water-slips-9-post-fy-results-provides-fy20-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alkaline Water slips 9% post FY results; provides FY20 guidance</a></h4><ul><li>The Alkaline Water Company (<a href='https://seekingalpha.com/symbol/WTER' title='The Alkaline Water Company Inc.'>WTER</a> <font color=\"red\">-9.8%</font>) reported FY revenue growth of 63% Y/Y to $32.2M.</li><li>With expansion into the convenience store market, company\u2019s core business in the national retail market exceeded expectations, with sales continuing to increase with many of the key customers, including Walmart, Kroger, Albertsons/Safeway, and CVS.</li><li>FY Gross profit of $12.9M (+58.8% Y/Y); and margin <font color=\"red\">declined by 80 bps</font> to 40.2%.</li><li>FY operating loss expanded to $8.06M, compared to $5.93M last year.</li><li>Operating expenses were $21.01M (+49.5% Y/Y); with sales &amp; marketing at $13.01M (+80.4% Y/Y) and G&amp;A at $7.42M (+15.5% Y/Y).</li><li>Net cash used in operating activities was $8.13M, compared to $2.65M a year ago. Company has Cash balance of $11.03M as of March 31, 2019.</li><li>Recent FY20 updates: Recorded monthly sales of over $3.8M of month ending May 31, 2019; Achieved record Q1 net sales of over $10M; and Revolving credit facility agreement extended to July, 2021.</li><li><strong>FY20 Guidance:</strong> Revenue of $46M to $50M; and Gross margin of $18M to $20M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3475148-alkaline-water-misses-revenue\" target=\"_blank\">Alkaline Water misses on revenue</a> (July 1)</li><li><a href=\"https://seekingalpha.com/filing/4552254\" target=\"_blank\">10-K</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3475364\" data-linked=\"Alkaline Water slips 9% post FY results; provides FY20 guidance\" data-tweet=\"$WTER - Alkaline Water slips 9% post FY results; provides FY20 guidance https://seekingalpha.com/news/3475364-alkaline-water-slips-9-post-fy-results-provides-fy20-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3475364-alkaline-water-slips-9-post-fy-results-provides-fy20-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475359\" data-ts=\"1562084750\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MZDAY\" target=\"_blank\">MZDAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475359-mazda-u-s-sales-down-15_1-in-june\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mazda U.S. sales down 15.1% in June</a></h4><ul> <li>Mazda (<a href='https://seekingalpha.com/symbol/MZDAY' title='Mazda Motor Corporation'>OTCPK:MZDAY</a>) unit sales <a href=\"https://seekingalpha.com/pr/17561970-mazda-reports-june-sales-results\" sasource=\"qp_sum_news_2\" target=\"_blank\">-15.1%</a> Y/Y in June to 22,828 units.</li><li>Car sales squeezed 32.1% to 6,430 units.</li><li>Truck sales slipped 5.9% to 16,398 units.</li><li>YTD Mazda U.S. sales decreased 15.5% to 138,555 units.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475359\" data-linked=\"Mazda U.S. sales down 15.1% in June\" data-tweet=\"$MZDAY - Mazda U.S. sales down 15.1% in June https://seekingalpha.com/news/3475359-mazda-u-s-sales-down-15_1-in-june?source=tweet\" data-url=\"https://seekingalpha.com/news/3475359-mazda-u-s-sales-down-15_1-in-june\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475357\" data-ts=\"1562084519\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UBER\" target=\"_blank\">UBER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475357-uber-expands-driver-debit-cards-to-mexico\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Uber expands driver debit cards to Mexico</a></h4><ul><li>Uber (<a href='https://seekingalpha.com/symbol/UBER' title='Uber Technologies, Inc.'>UBER</a> <font color='red'>-0.2%</font>) <a href=\"https://www.reuters.com/article/us-mexico-uber/uber-partners-with-bbva-mastercard-to-offer-debit-cards-in-mexico-idUSKCN1TX23N\" target=\"_blank\">partners</a> with Mastercard (<a href='https://seekingalpha.com/symbol/MA' title='Mastercard Incorporated'>MA</a> <font color='green'>+1%</font>) and BBVA (<a href='https://seekingalpha.com/symbol/BBVA' title='Banco Bilbao Vizcaya Argentaria, S.A.'>BBVA</a> <font color='red'>-0.6%</font>) bank to offer the debit card to drivers in Mexico, the first extension of a service offered in the United States.</li><li>The launch will start in six cities including Mexico City before rolling out across the country.</li><li>Drivers will not have to pay commissions to use the cards.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475357\" data-linked=\"Uber expands driver debit cards to Mexico\" data-tweet=\"$UBER $UBER $MA - Uber expands driver debit cards to Mexico https://seekingalpha.com/news/3475357-uber-expands-driver-debit-cards-to-mexico?source=tweet\" data-url=\"https://seekingalpha.com/news/3475357-uber-expands-driver-debit-cards-to-mexico\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475349\" data-ts=\"1562083708\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WMGI\" target=\"_blank\">WMGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475349-wright-medical-down-7-on-softer-prospects-for-cartiva-implant\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wright Medical down 7% on softer prospects for Cartiva implant</a></h4><ul><li>Wright Medical Group N.V. (<a href='https://seekingalpha.com/symbol/WMGI' title='Wright Medical Group N.V.'>WMGI</a> <font color=\"red\">-7.4%</font>) slumps on more than double normal volume in response to \"less positive\" market feedback on its <a href=\"https://www.cartiva.net/for-physicians/what-is-cartiva/\" target=\"_blank\">Cartiva </a>synthetic cartilage implant designed to treat osteoarthritis in the big toe joint.</li><li>In a note, RBC Capital analyst Brandon Henry says some early adopting surgeons have reduced usage, adding that recent data appears to suggest that the device \"may not be the panacea some initially hoped for.\" He has lowered his fair value target to $34 from $36 while maintaining his Outperform rating.</li><li>Shares also sold off on June 20 after Wells Fargo said a number of doctors had temporarily stopped using Cartiva due to concerns with durability.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475349\" data-linked=\"Wright Medical down 7% on softer prospects for Cartiva implant\" data-tweet=\"$WMGI - Wright Medical down 7% on softer prospects for Cartiva implant https://seekingalpha.com/news/3475349-wright-medical-down-7-on-softer-prospects-for-cartiva-implant?source=tweet\" data-url=\"https://seekingalpha.com/news/3475349-wright-medical-down-7-on-softer-prospects-for-cartiva-implant\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475344\" data-ts=\"1562083426\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475344-xcel-brands-only-consumer-gainer-bassett-furniture-industries-and-alkaline-water-company\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xcel Brands only consumer gainer; Bassett Furniture Industries and The Alkaline Water Company among losers</a></h4><ul><li><b>Gainers: </b>Xcel Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/XELB' title='Xcel Brands, Inc.'>XELB</a>) <font color=\"green\">+19%</font>.</li><li><b>Losers: </b>Bassett Furniture Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/BSET' title='Bassett Furniture Industries, Incorporated'>BSET</a>) <font color=\"red\">-12%</font>. Centric Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRC' title='Centric Brands Inc.'>CTRC</a>) <font color=\"red\">-8%</font>. Calyxt (NASDAQ:<a href='https://seekingalpha.com/symbol/CLXT' title='Calyxt, Inc.'>CLXT</a>) <font color=\"red\">-7%</font>. The Alkaline Water (NASDAQ:<a href='https://seekingalpha.com/symbol/WTER' title='The Alkaline Water Company Inc.'>WTER</a>) <font color=\"red\">-6%</font>. Mohawk Group (NASDAQ:<a href='https://seekingalpha.com/symbol/MWK' title='Mohawk Group Holdings, Inc.'>MWK</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475344\" data-linked=\"Xcel Brands only consumer gainer; Bassett Furniture Industries and The Alkaline Water Company among losers\" data-tweet=\"$XELB $BSET $CTRC - Xcel Brands only consumer gainer; Bassett Furniture Industries and The Alkaline Water Company among losers https://seekingalpha.com/news/3475344-xcel-brands-only-consumer-gainer-bassett-furniture-industries-and-alkaline-water-company?source=tweet\" data-url=\"https://seekingalpha.com/news/3475344-xcel-brands-only-consumer-gainer-bassett-furniture-industries-and-alkaline-water-company\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475331\" data-ts=\"1562081592\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NSANY\" target=\"_blank\">NSANY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475331-nissan-group-u-s-sales-down-14_9-in-june\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nissan Group U.S. sales down 14.9% in June</a></h4><ul><li>Nissan (<a href='https://seekingalpha.com/symbol/NSANY' title='Nissan Motor Co., Ltd.'>OTCPK:NSANY</a>) unit sales <a href=\"https://seekingalpha.com/pr/17561915-nissan-group-reports-june-2019-u-s-sales\" sasource=\"qp_sum_news_15\" target=\"_blank\">-14.9%</a> to 123,504 units vs. -10.2% forecast by Edmunds.</li><li>Nissan truck sales slipped 11.1% Y/Y to 70,771 units.</li><li>Nissan car sales fell 19.1% to 52,733 units.</li><li>Sales growth by brand: Nissan -15.4% to 113,665 units; Infiniti -8% to 9,839 units.</li><li>Nissan Altima sales dropped 38.6% and Maxima -53.8%.</li><li>Rogue sales fell 22.5% to 28,694 units during the month.</li><li>Titan sales squeezed 35.3% to 2,665 units.</li><li>YTD Nissan sales decreased 8.2% to 717,036 units.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475331\" data-linked=\"Nissan Group U.S. sales down 14.9% in June\" data-tweet=\"$NSANY $NSANF - Nissan Group U.S. sales down 14.9% in June https://seekingalpha.com/news/3475331-nissan-group-u-s-sales-down-14_9-in-june?source=tweet\" data-url=\"https://seekingalpha.com/news/3475331-nissan-group-u-s-sales-down-14_9-in-june\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475330\" data-ts=\"1562081561\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WLK\" target=\"_blank\">WLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475330-westlakeminus-2_8-analysts-weigh-in-on-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Westlake -2.8% as analysts weigh in on outlook</a></h4><ul><li>Westlake Chemical (<a href='https://seekingalpha.com/symbol/WLK' title='Westlake Chemical Corporation'>WLK</a> <font color='red'>-4%</font>) declines further as Barclays analyst Michael Leithead downgrades the stock to equal-weight from overweight, noting that cyclical pressures and valuation leaves risk/reward more balanced.</li><li>Tudor Pickering analyst Matthew Blair cuts his Q2 EPS for Westlake to 90 cents from $1.14; he also cuts his estimate for the chemical company's stock buyback in Q2 but keeps estimate for 2.5-cent-per-share dividend hike in Q3.</li><li>Quant rating<a href=\"https://seekingalpha.com/symbol/WLK/ratings/quant-ratings\" target=\"_blank\"> Neutral</a>; Sell-side average rating<a href=\"https://seekingalpha.com/symbol/WLK/ratings/sell-side-ratings\" target=\"_blank\"> Outperform </a>(5 Buy, 1 Outperform, 9 Hold, 1 Sell) previously.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3474899-westlake-chemical-minus-5-percent-lower-expected-q2-and-fy19-guidance\" target=\"_blank\">Westlake Chemical -5% on lower than expected Q2 &amp; FY19 guidance</a> (July 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3475330\" data-linked=\"Westlake -2.8% as analysts weigh in on outlook\" data-tweet=\"$WLK - Westlake -2.8% as analysts weigh in on outlook https://seekingalpha.com/news/3475330-westlakeminus-2_8-analysts-weigh-in-on-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3475330-westlakeminus-2_8-analysts-weigh-in-on-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475326\" data-ts=\"1562080535\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TM\" target=\"_blank\">TM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475326-toyota-motor-u-s-sales-declined-3_5-in-june\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Toyota Motor U.S. sales declined 3.5% in June</a></h4><ul><li>Toyota (<a href='https://seekingalpha.com/symbol/TM' title='Toyota Motor Corporation'>TM</a> <font color='green'>+1.1%</font>) unit sales <a href=\"https://seekingalpha.com/pr/17561869-toyota-motor-north-america-reports-u-s-sales-june-first-half-2019\" sasource=\"qp_sum_news_8\" target=\"_blank\">-3.5%</a> to 202,352 units vs. -4.4% forecast by Edmunds.</li><li>YTD unit sales down 3.1% to 1,152,108 units.</li><li>Toyota division sales slipped 3.5% to 179,305 units.</li><li>Lexus division sales decreased 3.4% to 23,047 units.</li><li>Total YARIS sales squeezed 21.8% to 1,925 units.</li><li>Total Corolla sales rose 2.5% to 28,869 units.</li><li>Camry sales up 2.4% to 28,889 units.</li><li>Prius sales down 26.5% to 5,769 units.</li><li>On the SUV front, RAV4 sales +3.8%, Highlander sales -8.2% and Land Cruiser +17.2%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475326\" data-linked=\"Toyota Motor U.S. sales declined 3.5% in June\" data-tweet=\"$TM - Toyota Motor U.S. sales declined 3.5% in June https://seekingalpha.com/news/3475326-toyota-motor-u-s-sales-declined-3_5-in-june?source=tweet\" data-url=\"https://seekingalpha.com/news/3475326-toyota-motor-u-s-sales-declined-3_5-in-june\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475322\" data-ts=\"1562080389\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGC\" target=\"_blank\">CGC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475322-global-cannabis-market-200b-in-next-decade-stifel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Global cannabis market $200B in next decade - Stifel</a></h4><ul><li>In the latest pie-in-sky <a href=\"https://www.marketwatch.com/story/cannabis-sector-could-grow-to-200-billion-in-a-decade-say-stifel-analysts-2019-07-02?siteid=bullytweet\" target=\"_blank\">forecast</a>, Stifel says the global cannabis market could reach $200B in the next 10 years, up from ~$8B in 2018.</li><li>Recent <a href=\"https://seekingalpha.com/news/3472881-canopy-growth-eps-misses-0_66-beats-net-revenue\" target=\"_blank\">results </a>for top cannabis producer Canopy Growth (<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a> <font color=\"red\">-2%</font>) reflect the underwhelming ramp to date. Sales in fiscal Q4 (calendar Q1) were C$94.1M. Loss/share was (C$0.98). Shares dropped on <a href=\"https://seekingalpha.com/news/3473281-canopy-slips-another-3-percent-margin-concerns\" target=\"_blank\">margin concerns</a>.</li><li>The most significant headwind is legal. Canada is the only G-7 member to date to fully legalize weed. Stifel believes that the market in the U.S.'s northern neighbor will be C$10B by 2023.</li><li>11 U.S. states have OK'd recreational use of pot thus far. 33 allow the medical use of cannabis (actually recreational use for many \"patients\").</li><li>Another headwind will be data from a range of ongoing studies assessing the long-term effects of cannabis consumption, highly unlikely to show increases in productivity or cognitive acuity.</li><li>Related tickers: Tilray (<a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a> <font color=\"red\">-2.9%</font>), Aurora Cannabis (<a href='https://seekingalpha.com/symbol/ACB' title='Aurora Cannabis Inc.'>ACB</a> <font color=\"red\">-1.9%</font>), Cronos Group (<a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group Inc.'>CRON</a> <font color=\"red\">-1.5%</font>)</li><li>ETFs: <a href='https://seekingalpha.com/symbol/MJ' title='ETFMG Alternative Harvest ETF'>MJ</a>, <a href='https://seekingalpha.com/symbol/SOIL' title='Global X Fertilizers/Potash ETF'>SOIL</a>, <a href='https://seekingalpha.com/symbol/ACT' title='AdvisorShares Vice ETF'>ACT</a>, <a href='https://seekingalpha.com/symbol/YOLO' title='AdvisorShares Pure Cannabis ETF'>YOLO</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3475322\" data-linked=\"Global cannabis market $200B in next decade - Stifel\" data-tweet=\"$CGC $TLRY $ACB - Global cannabis market $200B in next decade - Stifel https://seekingalpha.com/news/3475322-global-cannabis-market-200b-in-next-decade-stifel?source=tweet\" data-url=\"https://seekingalpha.com/news/3475322-global-cannabis-market-200b-in-next-decade-stifel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>71&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475321\" data-ts=\"1562079976\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475321-amarin-and-celyad-among-healthcare-gainers-cel-sci-and-oramed-pharmaceuticals-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amarin and Celyad among healthcare gainers; CEL-SCI and Oramed Pharmaceuticals among losers</a></h4><ul><li><b>Gainers: </b>Oasmia Pharmaceutical (NASDAQ:<a href='https://seekingalpha.com/symbol/OASM' title='Oasmia Pharmaceutical AB &#40;publ&#41;'>OASM</a>) <font color=\"green\">+21%</font>. Equillium (NASDAQ:<a href='https://seekingalpha.com/symbol/EQ' title='Equillium, Inc.'>EQ</a>) <font color=\"green\">+13%</font>. Celyad (NASDAQ:<a href='https://seekingalpha.com/symbol/CYAD' title='Celyad SA'>CYAD</a>) <font color=\"green\">+12%</font>. Amarin (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRN' title='Amarin Corporation plc'>AMRN</a>) <font color=\"green\">+10%</font>. Ovid Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OVID' title='Ovid Therapeutics Inc.'>OVID</a>) <font color=\"green\">+10%</font>.</li><li><b>Losers: </b>OncoCyte (NYSEMKT:<a href='https://seekingalpha.com/symbol/OCX' title='OncoCyte Corporation'>OCX</a>) <font color=\"red\">-17%</font>. Precipio (NASDAQ:<a href='https://seekingalpha.com/symbol/PRPO' title='Precipio, Inc.'>PRPO</a>) <font color=\"red\">-11%</font>. CEL-SCI (NYSEMKT:<a href='https://seekingalpha.com/symbol/CVM' title='CEL-SCI Corporation'>CVM</a>) <font color=\"red\">-9%</font>. Melinta Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MLNT' title='Melinta Therapeutics, Inc.'>MLNT</a>) <font color=\"red\">-9%</font>. Oramed Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ORMP' title='Oramed Pharmaceuticals Inc.'>ORMP</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475321\" data-linked=\"Amarin and Celyad among healthcare gainers; CEL-SCI and Oramed Pharmaceuticals among losers\" data-tweet=\"$OASM $EQ $CYAD - Amarin and Celyad among healthcare gainers; CEL-SCI and Oramed Pharmaceuticals among losers https://seekingalpha.com/news/3475321-amarin-and-celyad-among-healthcare-gainers-cel-sci-and-oramed-pharmaceuticals-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3475321-amarin-and-celyad-among-healthcare-gainers-cel-sci-and-oramed-pharmaceuticals-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475319\" data-ts=\"1562079830\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRTO\" target=\"_blank\">CRTO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475319-criteo-adds-customer-intelligence-partner\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Criteo adds customer intelligence partner</a></h4><ul><li>Criteo (NASDAQ:<a href='https://seekingalpha.com/symbol/CRTO' title='Criteo S.A.'>CRTO</a>) <a href=\"https://seekingalpha.com/pr/17561539-custora-announces-partnership-criteo\" target=\"_blank\">adds</a> customer intelligence platform Custora to its Global Audience Partner Program as part of a strategic partnership.</li><li>The tie-up combines Custora\u2019s platform to acquire and retain customers with Criteo\u2019s delivery of real-time, personalized dynamic ads.</li><li>Criteo shares are <font color=\"green\">up 1.3%</font> to $17.54.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475319\" data-linked=\"Criteo adds customer intelligence partner\" data-tweet=\"$CRTO - Criteo adds customer intelligence partner https://seekingalpha.com/news/3475319-criteo-adds-customer-intelligence-partner?source=tweet\" data-url=\"https://seekingalpha.com/news/3475319-criteo-adds-customer-intelligence-partner\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475317\" data-ts=\"1562079704\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JKS\" target=\"_blank\">JKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475317-jinkosolar-announces-upsized-syndicated-loan-agreement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JinkoSolar announces upsized syndicated loan agreement</a></h4><ul><li>JinkoSolar Holding's (<a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a> <font color='red'>-2.5%</font>) subsidiary has upsized a two-year JPY5.3B syndicated loan signed in June 2018 to JPY6.7B during its annual review in June 2019.</li><li>The financing will be used to expand JinkoSolar Japan's business and to supplement working capital.</li><li><a href=\"https://seekingalpha.com/pr/17561113-jinkosolar-announces-upsized-jpy6_7-billion-syndicated-loan-agreement-japanese-bank\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3475317\" data-linked=\"JinkoSolar announces upsized syndicated loan agreement\" data-tweet=\"$JKS - JinkoSolar announces upsized syndicated loan agreement https://seekingalpha.com/news/3475317-jinkosolar-announces-upsized-syndicated-loan-agreement?source=tweet\" data-url=\"https://seekingalpha.com/news/3475317-jinkosolar-announces-upsized-syndicated-loan-agreement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475315\" data-ts=\"1562079538\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GM\" target=\"_blank\">GM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475315-gm-sees-q2-u-s-deliveries-drop-on-chevy-weakness\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GM sees Q2 U.S. deliveries drop on Chevy weakness</a></h4><ul> <li>General Motors (<a href='https://seekingalpha.com/symbol/GM' title='General Motors Company'>GM</a> <font color='red'>-0.5%</font>) <a href=\"https://media.gm.com/media/us/en/gm/home.detail.html/content/Pages/news/us/en/2019/jul/0702-gmsales.html\" target=\"_blank\">reports</a> U.S. deliveries fell 1.5% in Q2 to 746,659 vehicles.</li> <li>The automaker's crossover deliveries set a new Q2 record after a 17% Y/Y jump.</li> <li>Deliveries by brand: Buick +4.7% to 55K, Cadillac +1.3% to 40K, Chevrolet -5.3% to 500K, GMC +9.8% to 152K.</li> <li>Model standouts: Chevrolet Spark +62% to 7.2K units, Chevy Tahoe +23% to 33K, Chevy Suburban +21% to 18K, GMC Canyon +24% to 12K, GMC Terrain +12% to 25K.</li> <li>\"Auto demand was better than anticipated in H1 and we expect strong performance in H2 of the year. If the Fed cuts rates, as widely expected, lower financing costs will provide further support to auto sales,\" notes GM Chief Economist Elaine Buckberg.</li> <li>GM\u2019s average transaction prices rose by $1,575 to a Q2 record of $37,126, compared to an industry average of $33,681, according to J.D. Power PIN estimates.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475315\" data-linked=\"GM sees Q2 U.S. deliveries drop on Chevy weakness\" data-tweet=\"$GM - GM sees Q2 U.S. deliveries drop on Chevy weakness https://seekingalpha.com/news/3475315-gm-sees-q2-u-s-deliveries-drop-on-chevy-weakness?source=tweet\" data-url=\"https://seekingalpha.com/news/3475315-gm-sees-q2-u-s-deliveries-drop-on-chevy-weakness\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475314\" data-ts=\"1562079445\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475314-oil-falls-disappointing-economic-data-comes-to-fore\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil falls as disappointing economic data comes to the fore</a></h4><ul><li>Dimmer global economic reports damp the effect of extended supply cuts agreed to by the OPEC+ group over the weekend, sending oil futures down.</li><li>Contracts for crude oil delivery in August<font color=\"red\"> fall 3.1% </font>to $57.27 per barrel on the New York Mercantile, snapping yesterday's rally.</li><li>United States Oil ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>), which invests in WTI crude futures, <font color=\"red\">drops 3.7%</font>, and State Street's Energy Select Sector SPDR ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>)<font color=\"red\"> slips 1.2%</font>.</li><li>Among XLE's holdings: Exxon Mobil (<a href='https://seekingalpha.com/symbol/XOM' title='Exxon Mobil Corporation'>XOM</a> <font color='red'>-1.2%</font>), Chevron (<a href='https://seekingalpha.com/symbol/CVX' title='Chevron Corporation'>CVX</a> <font color='red'>-1.8%</font>), (<a href='https://seekingalpha.com/symbol/COP' title='ConocoPhillips'>COP</a> <font color='red'>-2.2%</font>), EOG Resources (<a href='https://seekingalpha.com/symbol/EOG' title='EOG Resources, Inc.'>EOG</a> <font color='red'>-4.3%</font>), Occidental Petroleum (<a href='https://seekingalpha.com/symbol/OXY' title='Occidental Petroleum Corporation'>OXY</a> <font color='red'>-1.9%</font>).</li><li>Oil ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a></li><li>Energy equity ETFs: <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a>, <a href='https://seekingalpha.com/symbol/IXC' title='iShares Global Energy ETF'>IXC</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3475314\" data-linked=\"Oil falls as disappointing economic data comes to the fore\" data-tweet=\"$USO $XLE $XOM - Oil falls as disappointing economic data comes to the fore https://seekingalpha.com/news/3475314-oil-falls-disappointing-economic-data-comes-to-fore?source=tweet\" data-url=\"https://seekingalpha.com/news/3475314-oil-falls-disappointing-economic-data-comes-to-fore\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>118&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475306\" data-ts=\"1562078544\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OVID\" target=\"_blank\">OVID</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475306-ovid-up-10-on-advancement-of-ov101-in-angelman\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ovid up 10% on advancement of OV101 in Angelman</a></h4><ul><li>Investors appear to be waking up to Ovid Therapeutics (<a href='https://seekingalpha.com/symbol/OVID' title='Ovid Therapeutics Inc.'>OVID</a> <font color=\"green\">+10%</font>). Shares have rallied almost <font color=\"green\">40%</font> this week.</li><li>On June 27 at its <a href=\"https://seekingalpha.com/pr/17557576-ovid-therapeutics-initiates-pivotal-phase-3-clinical-trial-angelman-syndrome-multiple-data\" target=\"_blank\">R&amp;D Day</a>, it announced the initiation of a Phase 3 clinical trial, NEPTUNE, evaluating lead candidate OV101 in patients with an inherited nervous system disorder called <a href=\"https://www.angelman.org/\" target=\"_blank\">Angelman syndrome</a>.</li><li>Enrollment will commence this quarter with topline data expected by mid-2020. If all goes well, the results will support a U.S. marketing application.</li><li>This morning, it <a href=\"https://seekingalpha.com/pr/17561466-ovid-therapeutics-receives-orphan-drug-designation-european-commission-ov101-treatment\" target=\"_blank\">announced </a>Orphan Drug status in Europe for OV101 for Angelman.</li><li><a href=\"http://www.ovidrx.com/our-pipeline/\" target=\"_blank\">OV101</a> (gaboxadol) is a delta (δ)-selective GABAA receptor agonist designed to specifically target the disruption of tonic inhibition, a central physiological process of the brain that is believed to be the cause of certain neurodevelopmental disorders.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475306\" data-linked=\"Ovid up 10% on advancement of OV101 in Angelman\" data-tweet=\"$OVID - Ovid up 10% on advancement of OV101 in Angelman https://seekingalpha.com/news/3475306-ovid-up-10-on-advancement-of-ov101-in-angelman?source=tweet\" data-url=\"https://seekingalpha.com/news/3475306-ovid-up-10-on-advancement-of-ov101-in-angelman\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475303\" data-ts=\"1562078083\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CARS\" target=\"_blank\">CARS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475303-cars-complus-6-after-citi-defends\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cars.com +6% after Citi defends</a></h4><ul> <li>Citi is out with a defense of Cars.com (<a href='https://seekingalpha.com/symbol/CARS' title='Cars.com Inc.'>CARS</a> <font color='green'>+6.1%</font>) following the stocks's five-month stumble.</li> <li>\"We believe its current valuation is low even if we were to exclude the probability for an acquisition,\" updates analyst Nicholas Jones.</li> <li>Citi's price target of $27 on Cars.com reps 36% upside potential. The PT goes to $24 if M&amp;A potential is backed out of the equation.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475303\" data-linked=\"Cars.com +6% after Citi defends\" data-tweet=\"$CARS - Cars.com +6% after Citi defends https://seekingalpha.com/news/3475303-cars-complus-6-after-citi-defends?source=tweet\" data-url=\"https://seekingalpha.com/news/3475303-cars-complus-6-after-citi-defends\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475290\" data-ts=\"1562076866\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSK\" target=\"_blank\">GSK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475290-u-s-drugmakers-institute-new-round-of-increases\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. drugmakers institute new round of increases</a></h4><ul><li>Early July is typically one of the two times each calendar year that U.S. drugmakers hike prices. Yesterday, on cue, many <a href=\"https://www.wsj.com/articles/drugmakers-push-their-prices-higher-11562024649\" target=\"_blank\">appeared to do just that</a>.</li><li>B. Braun raised the price of its Isolyte saline solution by more than 100% to almost $6/package. Saline solutions, used to rehydrate patients and dilute medicines before administration, have been in short supply in the past few years.</li><li>GlaxoSmithKline (<a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline plc'>GSK</a> <font color=\"green\">+0.1%</font>) raised the price of ovarian cancer med Zejula (niraparib), acquired in Tesaro merger, by 5% to $6,913 for a 30-day supply.</li><li>Amneal Pharmaceuticals (<a href='https://seekingalpha.com/symbol/AMRX' title='Amneal Pharmaceuticals, Inc.'>AMRX</a> <font color=\"red\">-1.3%</font>) hiked the price of thyroid med Unithroid by ~10%.</li><li>According to Rx Savings Solutions, 20 companies raised prices on over 40 products by an average of 13.1%, both higher than July of last year when 16 firms boosted prices by an average of 7.8%.</li><li>Many pharmaceutical makers have pledged to restrict increases to less than 10% per annum. During Q1, list prices for U.S. branded drugs rose 3.3% versus 6.3% a year ago per SSR Health LLC.</li><li>Some observers believe that many companies may raise prices later this year when there is less attention on the issue.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/BIB' title='ProShares Ultra Nasdaq Biotechnology ETF'>BIB</a>, <a href='https://seekingalpha.com/symbol/GRX' title='The Gabelli Healthcare & Wellness Rx Trust'>GRX</a>, <a href='https://seekingalpha.com/symbol/THW' title='Tekla World Healthcare Fund'>THW</a>, <a href='https://seekingalpha.com/symbol/BME' title='BlackRock Health Sciences Trust'>BME</a>, <a href='https://seekingalpha.com/symbol/BIS' title='ProShares UltraShort Nasdaq Biotechnology ETF'>BIS</a>, <a href='https://seekingalpha.com/symbol/IXJ' title='iShares Global Healthcare ETF'>IXJ</a>, <a href='https://seekingalpha.com/symbol/ARKG' title='ARK Genomic Revolution Multi-Sector ETF'>ARKG</a>, <a href='https://seekingalpha.com/symbol/CHNA' title='The Loncar China BioPharma ETF'>CHNA</a>, <a href='https://seekingalpha.com/symbol/IDNA' title='iShares Genomics Immunology and Healthcare ETF'>IDNA</a>, <a href='https://seekingalpha.com/symbol/XLV' title='Health Care Select Sect SPDR ETF'>XLV</a></li><li>Selected tickers: Takeda (<a href='https://seekingalpha.com/symbol/TAK' title='Takeda Pharmaceutical Company Limited'>TAK</a> <font color=\"green\">+0.2%</font>), Bristol-Myers Squibb (<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color=\"green\">+1%</font>), Merck (<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co., Inc.'>MRK</a> <font color=\"green\">+0.3%</font>), Pfizer (<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color=\"green\">+0.8%</font>), Johnson &amp; Johnson (<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color=\"red\">-0.2%</font>), AbbVie (<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> <font color=\"red\">-0.4%</font>), Eli Lilly (<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a> <font color=\"green\">+0.7%</font>), Novartis (<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a> <font color=\"green\">+0.1%</font>), Roche (<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding AG'>OTCQX:RHHBY</a> <font color=\"green\">+0.1%</font>), Allergan (<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color=\"green\">+0.1%</font>), Amgen (<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a> <font color=\"red\">-0.3%</font>), Biogen (<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a> <font color=\"green\">+0.1%</font>), Gilead Sciences (<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a> <font color=\"green\">+1.4%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3475290\" data-linked=\"U.S. drugmakers institute new round of increases\" data-tweet=\"$GSK $AMRX $BIB - U.S. drugmakers institute new round of increases https://seekingalpha.com/news/3475290-u-s-drugmakers-institute-new-round-of-increases?source=tweet\" data-url=\"https://seekingalpha.com/news/3475290-u-s-drugmakers-institute-new-round-of-increases\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>96&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475291\" data-ts=\"1562076806\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARW\" target=\"_blank\">ARW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475291-arrowminus-1_8-on-cuts-raymond-james\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arrow -1.8% on cuts at Raymond James</a></h4><ul><li>Raymond James downgrades Arrow Electronics (NYSE:<a href='https://seekingalpha.com/symbol/ARW' title='Arrow Electronics, Inc.'>ARW</a>) from Strong Buy to Outperform and lowers the PT from $88 to $80, an 11% upside.</li><li>Arrow shares are <font color=\"red\">down 1.8%</font> to $70.68.</li><li>ARW has an Outperform <a href=\"https://seekingalpha.com/symbol/ARW/ratings/sell-side-ratings\" target=\"_blank\">average Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475291\" data-linked=\"Arrow -1.8% on cuts at Raymond James\" data-tweet=\"$ARW - Arrow -1.8% on cuts at Raymond James https://seekingalpha.com/news/3475291-arrowminus-1_8-on-cuts-raymond-james?source=tweet\" data-url=\"https://seekingalpha.com/news/3475291-arrowminus-1_8-on-cuts-raymond-james\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475288\" data-ts=\"1562076526\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/I\" target=\"_blank\">I</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475288-charter-cable-groups-propose-alternative-c-band-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Charter, cable groups propose alternative C-band plan</a></h4><ul>   <li>A push by Intelsat (NYSE:<a href='https://seekingalpha.com/symbol/I' title='Intelsat S.A.'>I</a>) at the FCC to study and approve monetizing mid-band satellite spectrum for use by wireless carriers is getting an alternative vision from Charter (<a href=\"http://seekingalpha.com/symbol/CHTR\" target=\"_blank\">CHTR</a> <font color=\"red\">-0.4%</font>) and cable groups.</li>    <li>A <a href=\"https://ccamobile.org/wp-content/uploads/2019/07/190701-Industry-C-Band-Proposal-FINAL.pdf\" target=\"_blank\">filing from Charter</a>, the Competitive Carrier Association and ACA Connects suggests that feeds that cable/TV outlets now get via the C-band spectrum be diverted over fiber, and that the FCC lead a C-band auction and send proceeds (potentially a multibillion-dollar windfall) to the U.S. Treasury.</li>    <li>The Charter group is calling for clearing 370 MHz -- almost twice the amount called for by the C-Band alliance, led by Intelsat, SES (<a href='https://seekingalpha.com/symbol/SGBAF' title='SES S.A.'>OTCPK:SGBAF</a>) and Intel (<a href=\"http://seekingalpha.com/symbol/INTC\" target=\"_blank\">INTC</a> <font color=\"red\">-0.3%</font>) -- and in half the time in urban areas called for by the CBA plan.</li>    <li>Intelsat is <font color=\"red\">down 2.7%</font> in U.S. trading, and SES is <font color=\"red\">down 2.5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475288\" data-linked=\"Charter, cable groups propose alternative C-band plan\" data-tweet=\"$I $SGBAF $I - Charter, cable groups propose alternative C-band plan https://seekingalpha.com/news/3475288-charter-cable-groups-propose-alternative-c-band-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/3475288-charter-cable-groups-propose-alternative-c-band-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475286\" data-ts=\"1562076402\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBX\" target=\"_blank\">GBX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475286-greenbrier-slumps-after-outlook-disappoints\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Greenbrier slumps after outlook disappoints</a></h4><ul> <li>Shares of Greenbrier (NYSE:<a href='https://seekingalpha.com/symbol/GBX' title='The Greenbrier Companies, Inc.'>GBX</a>) are <font color=\"red\">down 11.70%</font> after the company misses on both lines of its <a href=\"https://seekingalpha.com/pr/17561211-greenbrier-reports-third-quarter-results\" target=\"_blank\">FQ3 report</a> and issues downside guidance.</li> <li>The company expects FQ4 revenue of nearly $1B vs. $1.1B consensus and sees EPS of $1.30 to $1.50 vs. $1.89 consensus. Greenbrier anticipates FQ4 deliveries will be 7K to 8K units.</li> <li>Management's outlook: \"We anticipate further strong momentum in the fourth quarter.  Realignment of our railcar repair network is expected to be completed by the end of the year, which will help earnings performance in the Wheels, Repair &amp; Parts segment.  In Brazil, the long-delayed rail concession renewal process negatively affected the operations of our joint venture, resulting in a loss this quarter.  Greenbrier's Brazil operations are being right-sized for the current demand environment before order activity ramps up as expected in 2020 and over the coming years.  Meanwhile, pricing and manufacturing performance in Europe responded more slowly than expected, but is now kicking in. Headwinds from Europe and Brazil are expected to turn to tailwinds in Q4 and beyond, along with other international performance contributions.\"</li><li>Previously: <a href=\"https://seekingalpha.com/news/3475282-greenbrier-slides-11_9-percent-post-q3-results\" target=\"_blank\">Greenbrier slides 11.9% post Q3 results</a> (July 2)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475286\" data-linked=\"Greenbrier slumps after outlook disappoints\" data-tweet=\"$GBX - Greenbrier slumps after outlook disappoints https://seekingalpha.com/news/3475286-greenbrier-slumps-after-outlook-disappoints?source=tweet\" data-url=\"https://seekingalpha.com/news/3475286-greenbrier-slumps-after-outlook-disappoints\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475285\" data-ts=\"1562076319\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNP\" target=\"_blank\">CNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475285-centerpoint-gains-on-goldmans-conviction\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CenterPoint gains on Goldman&#39;s Conviction</a></h4><ul><li>Goldman Sachs adds CenterPoint Energy (NYSE:<a href='https://seekingalpha.com/symbol/CNP' title='CenterPoint Energy, Inc.'>CNP</a>) to its Conviction List.</li><li>Analyst Insoo Kim cites the recent share pullback and sees \"CNP as in the early stages of a turnaround story that may require investor patience near-term.\"</li><li>Kim expects CNP to achieve 6.9% EPS growth from 2018A-2012E, driven primarily by regulated utilities with more modest growth in unregulated.</li><li>CNP shares are <font color=\"green\">up 1.4%</font> to $28.90.</li><li>CNP has an Outperform <a href=\"https://seekingalpha.com/symbol/CNP/ratings/sell-side-ratings\" target=\"_blank\">average Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475285\" data-linked=\"CenterPoint gains on Goldman&#39;s Conviction\" data-tweet=\"$CNP - CenterPoint gains on Goldman&#39;s Conviction https://seekingalpha.com/news/3475285-centerpoint-gains-on-goldmans-conviction?source=tweet\" data-url=\"https://seekingalpha.com/news/3475285-centerpoint-gains-on-goldmans-conviction\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475282\" data-ts=\"1562075904\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475282-greenbrier-slides-11_9-post-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Greenbrier slides 11.9% post Q3 results</a></h4><ul><li>Greenbrier (<a href='https://seekingalpha.com/symbol/GBX' title='The Greenbrier Companies, Inc.'>GBX</a> <font color=\"red\">-11.9%</font>) reports <a href=\"https://seekingalpha.com/pr/17561211-greenbrier-reports-third-quarter-results\" target=\"_blank\">Q3</a> revenue growth of $856.2M (+33.5% Y/Y).</li><li>Q3 overall margins: Gross <font color=\"red\">declined 448 bps</font> to 12.45%; Operating <font color=\"red\">declined 494 bps</font> to 6.21% whereas Adj. EBITDA <font color=\"green\">increased 403 bps</font> to 9.86%.</li><li>Manufacturing: Revenue of 681.6M (+33.6% Y/Y); gross margin of 13.3%, <font color=\"green\">increased 640 bps</font> Q/Q; operating margin was 10.6%, an <font color=\"green\">increase of 770 bps</font> Q/Q &amp; deliveries of 6,500 units (+44.4% Q/Q).</li><li>Wheels, Repair &amp; Parts: Revenue of 125M (+32.3% Y/Y); gross margin of 4.1%, <font color=\"red\">declined 130 bps</font> Q/Q with operating margin of -7.1%.</li><li>Leasing &amp; Services: Revenue of 49.6M (+34.8% Y/Y); gross margin of 21.4%, <font color=\"red\">declined 300 bps</font> Q/Q &amp; operating margin was 30.9%, also <font color=\"red\">declined 580 bps</font> Q/Q.</li><li>Orders for 6,500 diversified railcars were received during the quarter, valued at $730M.</li><li>Book-to-bill ratio was 1.0x.</li><li>New railcar backlog as of May 31, 2019 was 26,100 units with an estimated value of $2.74B.</li><li>New railcar deliveries totaled 6,500 units for the quarter.</li><li>Board declares quarterly dividend of $0.25/share payable on August 8, 2019.</li><li>The acquisition of the manufacturing assets of ARI remains subject to regulatory review and approval.</li><li><b>Q4 2019 Outlook: </b>Revenue will be nearly $1B; EPS $1.30-1.50 excluding any ARI acquisition costs or operational benefits and deliveries will be 7,000-8,000 units including Greenbrier-Maxion (Brazil).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3475176-greenbrier-declares-0_25-dividend\" target=\"_blank\">Greenbrier declares $0.25 dividend</a> (Jul. 02 2019)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3475175-greenbrier-eps-misses-0_06-misses-revenue\" target=\"_blank\">Greenbrier EPS misses by $0.06, misses on revenue</a> (Jul. 02 2019)<b> </b></li></ul><div class=\"tiny-share-widget\" data-id=\"3475282\" data-linked=\"Greenbrier slides 11.9% post Q3 results\" data-tweet=\"$GBX - Greenbrier slides 11.9% post Q3 results https://seekingalpha.com/news/3475282-greenbrier-slides-11_9-post-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3475282-greenbrier-slides-11_9-post-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475280\" data-ts=\"1562075599\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COTY\" target=\"_blank\">COTY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475280-cotyminus-2-after-citi-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coty -2% after Citi downgrade</a></h4><ul> <li>Coty (NYSE:<a href='https://seekingalpha.com/symbol/COTY' title='Coty Inc.'>COTY</a>) is <font color=\"red\">down 2.16%</font> in early trading after Citi downgrades the beauty company to a Sell rating from Neutral.</li> <li>The firm thinks the Coty turnaround plan unveiled yesterday will take a long time to develop.</li> <li>Citi's new price target is $10 vs. $14 prior and the <a href=\"https://seekingalpha.com/symbol/COTY/ratings/sell-side-ratings\" target=\"_blank\">sell-side average PT</a> of $12.44.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475280\" data-linked=\"Coty -2% after Citi downgrade\" data-tweet=\"$COTY - Coty -2% after Citi downgrade https://seekingalpha.com/news/3475280-cotyminus-2-after-citi-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3475280-cotyminus-2-after-citi-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475279\" data-ts=\"1562075416\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMUS\" target=\"_blank\">TMUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475279-t-mobile-dish-agree-on-divestitures-for-sprint-merger-cnbc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">T-Mobile, Dish agree on divestitures for Sprint merger - CNBC</a></h4><ul>   <li>T-Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/TMUS' title='T-Mobile US, Inc.'>TMUS</a>) has <a href=\"https://www.cnbc.com/2019/07/02/t-mobile-dish-reach-divestiture-deal-pending-doj-concerns-sources.html\" target=\"_blank\">come to terms with Dish Network</a> (NASDAQ:<a href='https://seekingalpha.com/symbol/DISH' title='DISH Network Corporation'>DISH</a>) on divestitures required in order for T-Mobile to wrap its $26B merger with Sprint (NYSE:<a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a>), CNBC reports.</li>    <li>That's pending any concerns from the Justice Dept., though the process had been driven by DOJ's proposed remedy of selling Sprint's Boost Mobile and spectrum that could be used to help create a fourth national wireless carrier.</li>    <li>Shares are jumping: Sprint <font color=\"green\">+3.6%</font>; T-Mobile is <font color=\"green\">up 0.7%</font>; Dish Network <font color=\"green\">+3.5%</font>.</li>    <li>T-Mobile wants to limit wholesale capacity to 12.5%, while T-Mobile parent Deutsche Telekom (<a href=\"http://seekingalpha.com/symbol/DTEGY\" target=\"_blank\">DTEGY</a> <font color=\"red\">-0.2%</font>) wants to limit any strategic Dish investor to 5%, CNBC says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475279\" data-linked=\"T-Mobile, Dish agree on divestitures for Sprint merger - CNBC\" data-tweet=\"$TMUS $DISH $S - T-Mobile, Dish agree on divestitures for Sprint merger - CNBC https://seekingalpha.com/news/3475279-t-mobile-dish-agree-on-divestitures-for-sprint-merger-cnbc?source=tweet\" data-url=\"https://seekingalpha.com/news/3475279-t-mobile-dish-agree-on-divestitures-for-sprint-merger-cnbc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475273\" data-ts=\"1562074191\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPR\" target=\"_blank\">SPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475273-spirit-aerosystems-downgraded-on-737-max-uncertainty\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spirit AeroSystems downgraded on 737 Max uncertainty</a></h4><ul><li>Spirit AeroSystems (NYSE:<a href='https://seekingalpha.com/symbol/SPR' title='Spirit AeroSystems Holdings, Inc.'>SPR</a>) shares have \"limited upside\" given that the 737 Max represents ~50% of revenue, Jefferies analyst Sheila Kahyaoglu <a href=\"https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Jefferies+Downgrades+Spirit+AeroSystems+%28SPR%29+to+Hold/15667532.html\" target=\"_blank\">writes</a> in a new research note.</li><li>She downgrades the stock to Hold from Buy, and lowered her price target to $85 from $106.</li><li>Kahyaoglu also cut her 2019 and 2020 earnings per share estimates on SPR to $6.90 and $7.25 (from $7.10 and $7.70), respectively, to account for fewer 737 MAX shipset deliveries.</li><li>SPR <font color=\"red\">-0.4%</font> premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3475273\" data-linked=\"Spirit AeroSystems downgraded on 737 Max uncertainty\" data-tweet=\"$SPR - Spirit AeroSystems downgraded on 737 Max uncertainty https://seekingalpha.com/news/3475273-spirit-aerosystems-downgraded-on-737-max-uncertainty?source=tweet\" data-url=\"https://seekingalpha.com/news/3475273-spirit-aerosystems-downgraded-on-737-max-uncertainty\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475272\" data-ts=\"1562073974\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RTTR\" target=\"_blank\">RTTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475272-ritter-up-6-premarket-on-advancement-of-rp-g28\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ritter up 6% premarket on advancement of RP-G28</a></h4><ul><li>Ritter Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/RTTR' title='Ritter Pharmaceuticals, Inc.'>RTTR</a>) <a href=\"https://seekingalpha.com/pr/17561730-ritter-pharmaceuticals-announces-last-patient-last-visit-phase-3-liberatus-clinical-trial-rp\" target=\"_blank\">reports </a>that the last participant in its Phase 3 <a href=\"https://clinicaltrials.gov/ct2/show/NCT03597516?term=NCT03597516&amp;rank=1\" target=\"_blank\">Liberatus</a> study evaluating RP-G28 for the treatment of lactose intolerance has completed the final visit.</li><li>Topline data should be available in Q4.</li><li>Shares are up <font color=\"green\">6%</font> premarket on average volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475272\" data-linked=\"Ritter up 6% premarket on advancement of RP-G28\" data-tweet=\"$RTTR - Ritter up 6% premarket on advancement of RP-G28 https://seekingalpha.com/news/3475272-ritter-up-6-premarket-on-advancement-of-rp-g28?source=tweet\" data-url=\"https://seekingalpha.com/news/3475272-ritter-up-6-premarket-on-advancement-of-rp-g28\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475270\" data-ts=\"1562073760\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GTT\" target=\"_blank\">GTT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475270-gttminus-2_6-keybanc-cuts-on-growth-concerns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GTT -2.6% as KeyBanc cuts on growth concerns</a></h4><ul>   <li>GTT (NYSE:<a href='https://seekingalpha.com/symbol/GTT' title='GTT Communications, Inc.'>GTT</a>) is <font color=\"red\">2.6% lower</font> premarket alongside a cut to Sector Weight at KeyBanc, from Overweight.</li>    <li>The firm had been a bull based on a scenario with a \"smooth integration of acquisitions, more M&amp;A and organic growth\" -- factors that are \"not coming to fruition.\"</li>    <li>Hiring's still slow, which indicates growth will be in line with expectations at best, it says.</li>    <li>Sell-side analysts rate the stock an <a href=\"https://seekingalpha.com/symbol/GTT/ratings/sell-side-ratings\" target=\"_blank\">Outperform on average</a>, while it has a <a href=\"https://seekingalpha.com/symbol/GTT/ratings/quant-ratings\" target=\"_blank\">Quant Rating of Very Bearish</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475270\" data-linked=\"GTT -2.6% as KeyBanc cuts on growth concerns\" data-tweet=\"$GTT - GTT -2.6% as KeyBanc cuts on growth concerns https://seekingalpha.com/news/3475270-gttminus-2_6-keybanc-cuts-on-growth-concerns?source=tweet\" data-url=\"https://seekingalpha.com/news/3475270-gttminus-2_6-keybanc-cuts-on-growth-concerns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475267\" data-ts=\"1562073653\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DAL\" target=\"_blank\">DAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475267-deltaplus-2-on-reporting-june-traffic\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Delta +2% on reporting June traffic</a></h4><ul> <li>Delta Air Lines (NYSE:<a href='https://seekingalpha.com/symbol/DAL' title='Delta Air Lines, Inc.'>DAL</a>) reports revenue passenger miles rose <a href=\"https://seekingalpha.com/pr/17561703-delta-reports-operating-performance-june-2019\" sasource=\"qp_sum_news_12\" target=\"_blank\">6.2%</a> to 22.77B in June.</li><li>Domestic RPMs advanced 8% and international RPMs grew 3.4%.</li><li>Capacity increased 4% to 25.19B available seat miles.</li><li>Capacity up 4.4% for domestic and 3.3% internationally.</li><li>June Load factor expanded 190 bps to 90.4%.</li><li>YTD load factor +70 bps to 85.6%.</li><li>DAL <font color=\"green\">+2.23%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475267\" data-linked=\"Delta +2% on reporting June traffic\" data-tweet=\"$DAL - Delta +2% on reporting June traffic https://seekingalpha.com/news/3475267-deltaplus-2-on-reporting-june-traffic?source=tweet\" data-url=\"https://seekingalpha.com/news/3475267-deltaplus-2-on-reporting-june-traffic\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475266\" data-ts=\"1562073600\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475266-latest-tesla-exit-is-engineering-exec\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Latest Tesla exit is an engineering exec</a></h4><ul> <li>Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) engineering VP Steve MacManus has <a href=\"https://www.businessinsider.com.au/tesla-engineering-vp-steve-macmanus-departs-company-2019-6\" target=\"_blank\">left</a> the company, according to Business Insider.</li><li>The reason for the departure isn't known.</li> <li>The comings and going of engineering execs at the EV automaker draw even more interest than normal employee shuffling due to interest on where Tesla stands with its plans for pickup trucks and semi trucks.</li> <li>Shares of Tesla are <font color=\"green\">up 0.90%</font> premarket to $229.01.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3475266\" data-linked=\"Latest Tesla exit is an engineering exec\" data-tweet=\"$TSLA - Latest Tesla exit is an engineering exec https://seekingalpha.com/news/3475266-latest-tesla-exit-is-engineering-exec?source=tweet\" data-url=\"https://seekingalpha.com/news/3475266-latest-tesla-exit-is-engineering-exec\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>271&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475264\" data-ts=\"1562073533\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAXR\" target=\"_blank\">MAXR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475264-maxarplus-3_3-amid-report-thales-leonard-consider-joint-mda-bid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Maxar +3.3% amid report that Thales, Leonard consider joint MDA bid</a></h4><ul>   <li>Maxar Technologies (NYSE:<a href='https://seekingalpha.com/symbol/MAXR' title='Maxar Technologies Inc.'>MAXR</a>) is <font color=\"green\">up 3.3%</font> premarket after Reuters reports that Italy's Leonardo and France's Thales are <a href=\"https://www.reuters.com/article/us-leonardo-strategy/leonardo-thales-consider-joint-bid-for-maxars-mda-space-division-leonardo-ceo-idUSKCN1TX0OD\" target=\"_blank\">considering a joint bid</a> for Maxar's MDA space business.</li>    <li>Selling MacDonald, Dettwiler and Associates could draw $1B to put to work on Maxar's $3.2B debt pile.</li>    <li>\u201cFor us, they have a very good technology in the antennas for satellites, so it is an option we are considering,\u201d says Leonardo CEO Alessandro Profumo.</li>    <li>Thales and Leonardo already operate a joint venture, Thales Alenia Space, that is a Maxar customer.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475264\" data-linked=\"Maxar +3.3% amid report that Thales, Leonard consider joint MDA bid\" data-tweet=\"$MAXR - Maxar +3.3% amid report that Thales, Leonard consider joint MDA bid https://seekingalpha.com/news/3475264-maxarplus-3_3-amid-report-thales-leonard-consider-joint-mda-bid?source=tweet\" data-url=\"https://seekingalpha.com/news/3475264-maxarplus-3_3-amid-report-thales-leonard-consider-joint-mda-bid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475262\" data-ts=\"1562073407\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475262-eros-ocul-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EROS, OCUL among premarket gainers</a></h4><ul><li>Eros International (NYSE:<a href='https://seekingalpha.com/symbol/EROS' title='Eros International Plc'>EROS</a>) <font color=\"green\">+27%</font> <a href=\"https://seekingalpha.com/news/3475241-eros-plus-32-percent-interest-payment\" target=\"_blank\">after interest payment</a>.</li><li>Reebonz Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/RBZ' title='Reebonz Holding Limited'>RBZ</a>) <font color=\"green\">+17%</font> on <a href=\"https://seekingalpha.com/pr/17561311-reebonz-expands-sell-reebonz-service-malaysia-indonesia-hong-kong-taiwan-australia\" target=\"_blank\">expanding</a> its recently launched \u201cSell to Reebonz\u201d service to five new markets.</li><li>UP Fintech Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/TIGR' title='UP Fintech Holding Limited'>TIGR</a>) <font color=\"green\">+9%</font> on <a href=\"https://seekingalpha.com/pr/17561171-fintech-holding-limited-obtains-self-clearing-license-u-s-acquisition\" target=\"_blank\">obtaining</a> self-clearing license in the U.S. through acquisition.</li><li>Amarin Corporation plc (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRN' title='Amarin Corporation plc'>AMRN</a>) <font color=\"green\">+7%</font> on <a href=\"https://seekingalpha.com/news/3475189-amarin-8-percent-premarket-guidance-boost\" target=\"_blank\">guidance boost</a>.</li><li>The Alkaline Water (NASDAQ:<a href='https://seekingalpha.com/symbol/WTER' title='The Alkaline Water Company Inc.'>WTER</a>) <font color=\"green\">+7%</font> on <a href=\"https://seekingalpha.com/news/3475148-alkaline-water-misses-revenue\" target=\"_blank\">FY results</a>.</li><li>Globus Maritime (NASDAQ:<a href='https://seekingalpha.com/symbol/GLBS' title='Globus Maritime Limited'>GLBS</a>) <font color=\"green\">+6%</font> as <a href=\"https://seekingalpha.com/news/3475231-shipping-prices-uptrend\" target=\"_blank\">shipping prices</a> in an uptrend.</li><li>Ocular Therapeutix (NASDAQ:<a href='https://seekingalpha.com/symbol/OCUL' title='Ocular Therapeutix, Inc.'>OCUL</a>) <font color=\"green\">+6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475262\" data-linked=\"EROS, OCUL among premarket gainers\" data-tweet=\"$EROS $RBZ $TIGR - EROS, OCUL among premarket gainers https://seekingalpha.com/news/3475262-eros-ocul-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3475262-eros-ocul-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475261\" data-ts=\"1562073224\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMI\" target=\"_blank\">CMI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475261-economic-outlook-prompts-cummins-downgrade-loop\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Economic outlook prompts Cummins downgrade at Loop</a></h4><ul><li>Despite positive headlines on trade this past weekend, Loop Capital analyst Jeffrey Kaufman continues to see a broader-based deterioration in the level of activity across the U.S. and global economy.</li><li>This is leading to higher inventories, resulting in a broadening out in levels of weaker demand for both rail and truck traffic, and creating a more problematic outlook.</li><li>As a result, Kaufman <a href=\"https://www.streetinsider.com/Analyst+PT+Change/Loop+Capital+Downgrades+Cummins+%28CMI%29+to+Sell/15668063.html\" target=\"_blank\">downgrades</a> Cummins (NYSE:<a href='https://seekingalpha.com/symbol/CMI' title='Cummins Inc.'>CMI</a>) to Sell from Hold and lowered his PT on shares to $145 (from $168).</li><li>CMI <font color=\"red\">-1.3%</font> premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3475261\" data-linked=\"Economic outlook prompts Cummins downgrade at Loop\" data-tweet=\"$CMI - Economic outlook prompts Cummins downgrade at Loop https://seekingalpha.com/news/3475261-economic-outlook-prompts-cummins-downgrade-loop?source=tweet\" data-url=\"https://seekingalpha.com/news/3475261-economic-outlook-prompts-cummins-downgrade-loop\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475257\" data-ts=\"1562073113\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRGO\" target=\"_blank\">PRGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475257-perrigo-up-2-premarket-on-guidance-boost\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Perrigo up 2% premarket on guidance boost</a></h4><ul><li>Following the close of its Ranir Global Holdings buy, Perrigo (NYSE:<a href='https://seekingalpha.com/symbol/PRGO' title='Perrigo Company plc'>PRGO</a>) bumps its <a href=\"https://seekingalpha.com/pr/17561630-perrigo-completes-acquisition-ranir-raises-guidance\" target=\"_blank\">2019 non-GAAP EPS guidanc</a>e up $0.10.</li><li>Shares are up <font color=\"green\">2% </font>premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475257\" data-linked=\"Perrigo up 2% premarket on guidance boost\" data-tweet=\"$PRGO - Perrigo up 2% premarket on guidance boost https://seekingalpha.com/news/3475257-perrigo-up-2-premarket-on-guidance-boost?source=tweet\" data-url=\"https://seekingalpha.com/news/3475257-perrigo-up-2-premarket-on-guidance-boost\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475256\" data-ts=\"1562073033\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475256-gbx-tnxp-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GBX, TNXP among premarket losers</a></h4><ul><li>OncoCyte (NYSEMKT:<a href='https://seekingalpha.com/symbol/OCX' title='OncoCyte Corporation'>OCX</a>) <font color=\"red\">-16%</font>.</li><li>Tonix Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a>) <font color=\"red\">-10%</font> after <a href=\"https://seekingalpha.com/news/3475147-tonix-pharma-raising-capital-shares-14-percent\" target=\"_blank\">capital raise</a>.</li><li>The Greenbrier (NYSE:<a href='https://seekingalpha.com/symbol/GBX' title='The Greenbrier Companies, Inc.'>GBX</a>) <font color=\"red\">-8%</font> on <a href=\"https://seekingalpha.com/news/3475175-greenbrier-eps-misses-0_06-misses-revenue\" target=\"_blank\">Q3 earnings</a>.</li><li>Ceragon Networks (NASDAQ:<a href='https://seekingalpha.com/symbol/CRNT' title='Ceragon Networks Ltd.'>CRNT</a>) <font color=\"red\">-7%</font> on <a href=\"https://seekingalpha.com/news/3475180-ceragon-revises-revenue-guidance-amid-delay-receiving-large-orders\" target=\"_blank\">revising</a> Q2 revenue guidance due to delay in receiving large orders.</li><li>Foresight Autonomous (NASDAQ:<a href='https://seekingalpha.com/symbol/FRSX' title='Foresight Autonomous Holdings Ltd.'>FRSX</a>) <font color=\"red\">-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475256\" data-linked=\"GBX, TNXP among premarket losers\" data-tweet=\"$OCX $TNXP $GBX - GBX, TNXP among premarket losers https://seekingalpha.com/news/3475256-gbx-tnxp-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3475256-gbx-tnxp-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475246\" data-ts=\"1562072196\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLNT\" target=\"_blank\">MLNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475246-melinta-down-6-premarket-on-inability-to-draw-additional-funds-from-loan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Melinta down 6% premarket on inability to draw additional funds from loan</a></h4><ul><li>Citing a \"lack of clarity\" regarding its ability to meet certain requirements under its loan with Vatera Investment Partners LLC, Melinta Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MLNT' title='Melinta Therapeutics, Inc.'>MLNT</a>) <a href=\"https://www.sec.gov/Archives/edgar/data/1461993/000119312519187483/d736423d8k.htm\" target=\"_blank\">discloses </a>that it will unable to draw additional funds under the $135M loan.</li><li>It drew $75M in February. The remaining $60M was available in two draws, up to $25M after March 31 and on or prior to June 30 and up to $35M after June 30 and on or prior to July 10, subject to conditions.</li><li>The parties amended the loan agreement on June 28, reducing the available funds to $27M from $60M and extending the period to draw the money.</li><li>Shares are down <font color=\"red\">5%</font> premarket on modest volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475246\" data-linked=\"Melinta down 6% premarket on inability to draw additional funds from loan\" data-tweet=\"$MLNT - Melinta down 6% premarket on inability to draw additional funds from loan https://seekingalpha.com/news/3475246-melinta-down-6-premarket-on-inability-to-draw-additional-funds-from-loan?source=tweet\" data-url=\"https://seekingalpha.com/news/3475246-melinta-down-6-premarket-on-inability-to-draw-additional-funds-from-loan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475243\" data-ts=\"1562071645\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KAR\" target=\"_blank\">KAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475243-kar-auction-servicesminus-5-after-guggenheim-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KAR Auction Services -5% after Guggenheim cut</a></h4><ul> <li>Shares of KAR Auction Services (NYSE:<a href='https://seekingalpha.com/symbol/KAR' title='KAR Auction Services, Inc.'>KAR</a>) slide in early trading after Guggenheim lowers its rating to Sell from Neutral due to increased industry competition and cyclical headwinds.</li> <li>Guggenheim's new view aligns with the <a href=\"https://seekingalpha.com/symbol/KAR/ratings/quant-ratings\" target=\"_blank\">Seeking Quant rating</a> of Very Bearish. The firm drops its price target to $20.</li> <li>KAR <font color=\"red\">-4.76%</font> premarket to $24.01 vs. the 52-week trading range of $23.43 to $64.55.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475243\" data-linked=\"KAR Auction Services -5% after Guggenheim cut\" data-tweet=\"$KAR $IAA $KAR - KAR Auction Services -5% after Guggenheim cut https://seekingalpha.com/news/3475243-kar-auction-servicesminus-5-after-guggenheim-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3475243-kar-auction-servicesminus-5-after-guggenheim-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475241\" data-ts=\"1562071443\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EROS\" target=\"_blank\">EROS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475241-erosplus-32-after-interest-payment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eros +32% after interest payment</a></h4><ul><li>Eros (NYSE:<a href='https://seekingalpha.com/symbol/EROS' title='Eros International Plc'>EROS</a>) <a href=\"https://seekingalpha.com/pr/17561514-eros-international-plc-provides-business-update\" target=\"_blank\">announces</a> its Indian operating subsidiary EIML has paid its outstanding interest payments, which had led to CARE ratings downgrade.</li><li>The company says it's working with CARE to try to restore its previous investment grade rating.</li><li>In other news, Eros says outside director Jyoti Deshpande of Reliance Industries left the board on June 28 for other commitments.</li><li>The company's strategic review is still ongoing.</li><li>EROS shares are <font color=\"green\">up 32.7%</font> pre-market to $1.99.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475241\" data-linked=\"Eros +32% after interest payment\" data-tweet=\"$EROS - Eros +32% after interest payment https://seekingalpha.com/news/3475241-erosplus-32-after-interest-payment?source=tweet\" data-url=\"https://seekingalpha.com/news/3475241-erosplus-32-after-interest-payment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475240\" data-ts=\"1562071366\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JWN\" target=\"_blank\">JWN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475240-ubs-loses-faith-in-nordstrom\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UBS loses faith in Nordstrom</a></h4><ul> <li>UBS drops Nordstrom (NYSE:<a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom, Inc.'>JWN</a>) to a Neutral rating after having the department store operator slotted at Buy.</li> <li>The UBS analyst team points to a weaker competitive position for Nordstrom in the new retail landscape.</li> <li>UBS' price target on Nordstrom is slashed to $33 from $65, even lower than the <a href=\"https://seekingalpha.com/symbol/JWN/ratings/sell-side-ratings\" target=\"_blank\">sell-side average PT</a> of $37.28.</li> <li>Shares of Nordstrom are <font color=\"red\">down 1.27%</font> premarket to $31.09. The 52-week low is $30.55.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475240\" data-linked=\"UBS loses faith in Nordstrom\" data-tweet=\"$JWN - UBS loses faith in Nordstrom https://seekingalpha.com/news/3475240-ubs-loses-faith-in-nordstrom?source=tweet\" data-url=\"https://seekingalpha.com/news/3475240-ubs-loses-faith-in-nordstrom\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475239\" data-ts=\"1562071081\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VCYT\" target=\"_blank\">VCYT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475239-evercore-softens-view-on-stryker-in-premarket-analyst-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evercore softens view on Stryker in premarket analyst action</a></h4><ul><li>Veracyte (NASDAQ:<a href='https://seekingalpha.com/symbol/VCYT' title='Veracyte, Inc.'>VCYT</a>) initiated with Buy rating and $33 (15% upside) price target at Needham.</li><li>PRA Health Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/PRAH' title='PRA Health Sciences, Inc.'>PRAH</a>) initiated with Market Perform rating and $105 (7% upside) price target at SVB Leerink.</li><li>Bio-Techne (NASDAQ:<a href='https://seekingalpha.com/symbol/TECH' title='Bio-Techne Corporation'>TECH</a>) upgraded to Buy with a $270 (29% upside) price target at Janney Montgomery.</li><li>Dova Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/DOVA' title='Dova Pharmaceuticals, Inc.'>DOVA</a>) upgraded to Outperform at Evercore ISI. Shares up <font color=\"green\">5%</font> premarket.</li><li>Teladoc (NYSE:<a href='https://seekingalpha.com/symbol/TDOC' title='Teladoc Health, Inc.'>TDOC</a>) removed from Franchise Pick List at Jefferies.</li><li>Stryker (NYSE:<a href='https://seekingalpha.com/symbol/SYK' title='Stryker Corporation'>SYK</a>) downgraded to In Line with a $210 (2% upside) price target at Evercore ISI.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475239\" data-linked=\"Evercore softens view on Stryker in premarket analyst action\" data-tweet=\"$VCYT $PRAH $TECH - Evercore softens view on Stryker in premarket analyst action https://seekingalpha.com/news/3475239-evercore-softens-view-on-stryker-in-premarket-analyst-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3475239-evercore-softens-view-on-stryker-in-premarket-analyst-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475232\" data-ts=\"1562070520\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LYFT\" target=\"_blank\">LYFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475232-stifel-raises-lyfts-pt-enters-uber-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stifel raises Lyft&#39;s PT, enters Uber sidelines</a></h4><ul><li>Stifel analyst Scott Devitt maintains a Buy rating on Lyft (NASDAQ:<a href='https://seekingalpha.com/symbol/LYFT' title='Lyft, Inc.'>LYFT</a>) and raises the target from $70 to $76.</li><li>Devitt says rider incentives are being decreased across the ride-hail industry but cites the <a href=\"https://seekingalpha.com/news/3474334-waymo-launches-self-driving-lyfts\" target=\"_blank\">Waymo partnership</a> and <a href=\"https://seekingalpha.com/news/3473927-lyft-gets-medicaid-approval-arizona\" target=\"_blank\">healthcare transportation</a> wins will keep Lyft at the forefront of innovation.</li><li>The analyst raises his rider growth expectations for the rest of 2019 and 2020 to +5.3M /+3.9M active rider net adds, up from +5.0M /+3.6M.</li><li>Related: Devitt starts Uber (NYSE:<a href='https://seekingalpha.com/symbol/UBER' title='Uber Technologies, Inc.'>UBER</a>) at Neutral and a $50 price target, citing a loss of market share to Lyft, slower revenue growth, and a long road towards profitability.</li><li>Lyft shares are <font color=\"green\">up 1.1%</font> pre-market to $62.70. Uber shares are <font color=\"green\">up 0.5%</font> pre-market to $44.50.</li><li>Lyft has an Outperform average <a href=\"https://seekingalpha.com/symbol/LYFT/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475232\" data-linked=\"Stifel raises Lyft&#39;s PT, enters Uber sidelines\" data-tweet=\"$LYFT $UBER - Stifel raises Lyft&#39;s PT, enters Uber sidelines https://seekingalpha.com/news/3475232-stifel-raises-lyfts-pt-enters-uber-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3475232-stifel-raises-lyfts-pt-enters-uber-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475229\" data-ts=\"1562069806\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IOVA\" target=\"_blank\">IOVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475229-iovance-up-4-premarket-on-bullish-registration-path-for-lnminus-145\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Iovance up 4% premarket on bullish registration path for LN-145</a></h4><ul><li>Iovance Biotherapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/IOVA' title='Iovance Biotherapeutics, Inc.'>IOVA</a>) perks up <font color=\"green\">4%</font> premarket on light volume in reaction to <a href=\"https://seekingalpha.com/pr/17561357-iovance-biotherapeutics-provides-cervical-cancer-program-updates-following-end-phase-2\" target=\"_blank\">positive developments</a> on the regulatory pathway for Fast Track- and Breakthrough Therapy-tagged LN-145.</li><li>Based on FDA feedback from its End of Phase 2 meeting with the agency, the company says its ongoing Phase 2 <a href=\"https://clinicaltrials.gov/ct2/show/NCT03108495?term=iovance+biotherapeutics&amp;rank=4\" target=\"_blank\">innovaTIL-04</a> study in cervical cancer may be sufficient to support a U.S. marketing application based on a clearer definition of the patient population, specifically, patients who have progressed following first-line systemic treatment for recurrent/metastatic cervical cancer. This population comprises almost all of the advanced patients enrolled in the trial to date.</li><li><a href=\"https://www.iovance.com/clinical/c-145-04-cervical-carcinoma/\" target=\"_blank\">LN-145</a> is a tumor-infiltrating lymphocyte therapy derived from the patient's own immune cells (T lymphocytes). The cells are isolated from the patient's tumor, expanded in the laboratory, then infused back into the patient where they recognize and kill cancer cells. Patients also receive pre-conditioning therapy to reduce the immune suppressive environment of the cancer and up to six doses of interleukin 2 (IL-2) after LN-145 infusion to support the growth and activation of the TIL therapy.</li><li>The company expects to file its BLA in H2 2020.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475229\" data-linked=\"Iovance up 4% premarket on bullish registration path for LN-145\" data-tweet=\"$IOVA - Iovance up 4% premarket on bullish registration path for LN-145 https://seekingalpha.com/news/3475229-iovance-up-4-premarket-on-bullish-registration-path-for-lnminus-145?source=tweet\" data-url=\"https://seekingalpha.com/news/3475229-iovance-up-4-premarket-on-bullish-registration-path-for-lnminus-145\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475223\" data-ts=\"1562069078\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROKU\" target=\"_blank\">ROKU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475223-rbc-cuts-roku-on-valuation-rokuminus-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RBC cuts Roku on valuation; ROKU -3%</a></h4><ul><li>RBC steps from Outperform to the Roku (NASDAQ:<a href='https://seekingalpha.com/symbol/ROKU' title='Roku, Inc.'>ROKU</a>) sidelines with a $90 price target.</li><li>The firm cites valuation after shares rose more than 200% since a December low, though some of that rally was pared in June.</li><li>Analyst Mark Mahaney calls the risk/reward less balanced at the current valuation, but notes the share advance was justified by sustainable robust growth and profitability levels.</li><li>Mahaney recommends buying Roku on any major pullback.</li><li>Roku shares are <font color=\"red\">down 2.9%</font> pre-market to $88.68.</li><li>Roku has a Neutral <a href=\"https://seekingalpha.com/symbol/ROKU/ratings/quant-ratings\" target=\"_blank\">Quant rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475223\" data-linked=\"RBC cuts Roku on valuation; ROKU -3%\" data-tweet=\"$ROKU - RBC cuts Roku on valuation; ROKU -3% https://seekingalpha.com/news/3475223-rbc-cuts-roku-on-valuation-rokuminus-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3475223-rbc-cuts-roku-on-valuation-rokuminus-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475222\" data-ts=\"1562069047\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LSTR\" target=\"_blank\">LSTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475222-landstar-system-shakes-off-bear-call\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Landstar System shakes off bear call</a></h4><ul> <li>Landstar System (NASDAQ:<a href='https://seekingalpha.com/symbol/LSTR' title='Landstar System, Inc.'>LSTR</a>) is on watch after Raymond James moves to Market Perform from Underperform.</li> <li>Landstar has a consensus sell-side rating of Hold and a <a href=\"https://seekingalpha.com/symbol/LSTR/ratings/quant-ratings\" target=\"_blank\">Seeking Alpha Quant Rating</a> of Neutral.</li> <li>Shares of Landstar are <font color=\"green\">up 0.54%</font> premarket to $108.53 vs. the 52-week trading range of $90.23 to $128.70.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475222\" data-linked=\"Landstar System shakes off bear call\" data-tweet=\"$LSTR - Landstar System shakes off bear call https://seekingalpha.com/news/3475222-landstar-system-shakes-off-bear-call?source=tweet\" data-url=\"https://seekingalpha.com/news/3475222-landstar-system-shakes-off-bear-call\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475219\" data-ts=\"1562068623\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLAY\" target=\"_blank\">PLAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475219-dave-bustersminus-1_5-after-jefferies-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dave &amp; Buster&#39;s -1.5% after Jefferies downgrade</a></h4><ul> <li>Jefferies lowers Dave &amp; Buster's Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/PLAY' title='Dave & Buster&#39;s Entertainment, Inc.'>PLAY</a>) to a Hold rating from Buy on concerns of new traffic competition for the chain.</li> <li>The firm drops its price target on D&amp;B to $50 from $56 vs. the <a href=\"https://seekingalpha.com/symbol/PLAY/ratings/sell-side-ratings\" target=\"_blank\">average sell-side PT</a> of $50.64.</li> <li>Shares of PLAY are <font color=\"red\">down 1.47%</font> premarket to $39.45.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475219\" data-linked=\"Dave &amp; Buster&#39;s -1.5% after Jefferies downgrade\" data-tweet=\"$PLAY - Dave &amp; Buster&#39;s -1.5% after Jefferies downgrade https://seekingalpha.com/news/3475219-dave-bustersminus-1_5-after-jefferies-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3475219-dave-bustersminus-1_5-after-jefferies-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475217\" data-ts=\"1562068482\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XBIO\" target=\"_blank\">XBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475217-xenetic-bio-readies-equity-offering-shares-down-8-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xenetic Bio readies equity offering; shares down 8% premarket</a></h4><ul><li>Xenetic Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/XBIO' title='Xenetic Biosciences, Inc.'>XBIO</a>) has <a href=\"https://www.sec.gov/Archives/edgar/data/1534525/000168316819002077/xenetic_s1a3.htm\" target=\"_blank\">filed</a> a preliminary prospectus for a public offering of 1,555,555 common shares and warrants to purchase same number of common shares, at a combined price of $11.25 per share and warrant.</li><li>Shares are down <font color=\"red\">8%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475217\" data-linked=\"Xenetic Bio readies equity offering; shares down 8% premarket\" data-tweet=\"$XBIO - Xenetic Bio readies equity offering; shares down 8% premarket https://seekingalpha.com/news/3475217-xenetic-bio-readies-equity-offering-shares-down-8-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3475217-xenetic-bio-readies-equity-offering-shares-down-8-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475211\" data-ts=\"1562067677\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EA\" target=\"_blank\">EA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475211-apex-legends-reaction-drives-ea-pt-boost\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">&#39;Apex Legends&#39; reaction drives EA PT boost</a></h4><ul><li>BMO maintains an Outperform rating on Electronic Arts (NASDAQ:<a href='https://seekingalpha.com/symbol/EA' title='Electronic Arts Inc.'>EA</a>) and raises the target from $116 to $130.</li><li>Analyst Gerrick Johnson cites \"increased confidence\" EA will top FY20 expectations \"owing to positive reaction to <em>Apex Legends</em> season 2 previews.\"</li><li>Johnson says sentiment is \"depressed\" and that the valuation \"looks compelling.\"</li><li>EA shares are <font color=\"green\">up 0.7%</font> pre-market to $101.60.</li><li>EA has an Outperform average <a href=\"https://seekingalpha.com/symbol/EA/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475211\" data-linked=\"&#39;Apex Legends&#39; reaction drives EA PT boost\" data-tweet=\"$EA - &#39;Apex Legends&#39; reaction drives EA PT boost https://seekingalpha.com/news/3475211-apex-legends-reaction-drives-ea-pt-boost?source=tweet\" data-url=\"https://seekingalpha.com/news/3475211-apex-legends-reaction-drives-ea-pt-boost\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475207\" data-ts=\"1562067156\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTD\" target=\"_blank\">TTD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475207-trade-deskminus-2-rbc-hits-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trade Desk -2% as RBC hits sidelines</a></h4><ul><li>RBC downgrades The Trade Desk (NASDAQ:<a href='https://seekingalpha.com/symbol/TTD' title='The Trade Desk, Inc.'>TTD</a>) from Outperform to Sector Perform as shares hit the $220 price target.</li><li>Analyst Mark Mahaney says his thesis remains \"very much intact,\" noting that the dramatic outperformance of TTD shares is justified by strong customer retention, solid Next Wave platform adoption, and hyper-growth segment exposure.</li><li>Mahaney says the risk/reward balance has become less attractive but concedes the downgrade could be wrong if CTV achieves better than expected revenue growth or China revenue growth becomes material earlier than expected.</li><li>TTD shares are <font color=\"red\">down 2%</font> pre-market to $229.20.</li><li>Trade Desk has a Neutral <a href=\"https://seekingalpha.com/symbol/TTD/ratings/quant-ratings\" target=\"_blank\">Quant rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475207\" data-linked=\"Trade Desk -2% as RBC hits sidelines\" data-tweet=\"$TTD - Trade Desk -2% as RBC hits sidelines https://seekingalpha.com/news/3475207-trade-deskminus-2-rbc-hits-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3475207-trade-deskminus-2-rbc-hits-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475197\" data-ts=\"1562066309\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDC\" target=\"_blank\">WDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475197-wdc-cut-on-too-far-rally\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WDC cut on &#39;too far&#39; rally</a></h4><ul><li>Benchmark cuts Western Digital (NASDAQ:<a href='https://seekingalpha.com/symbol/WDC' title='Western Digital Corporation'>WDC</a>) from Hold to Sell with a $40 price target.</li><li>The firm cites a share rally that has gone \"too far, too fast\" despite the US-China <a href=\"https://seekingalpha.com/news/3474854-semis-gain-us-china-trade-truce\" target=\"_blank\">trade truce</a>, <a href=\"https://seekingalpha.com/news/3473779-semis-boosted-micron-earnings-huawei-workaround\" target=\"_blank\">optimistic results</a> from Micron, and a <a href=\"https://seekingalpha.com/news/3474572-firm-sees-upsides-wdcs-power-outage\" target=\"_blank\">power outage</a> analysts say could help WDC's pricing.</li><li>Analyst Mark Miller says those factors are already baked into the valuation and the potential higher prices don't offset the decline in NAND prices.</li><li>WDC shares are <font color=\"red\">down 2.6%</font> pre-market to $48.37.</li><li>Western Digital has a Neutral <a href=\"https://seekingalpha.com/symbol/WDC/ratings/quant-ratings\" target=\"_blank\">Quant rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475197\" data-linked=\"WDC cut on &#39;too far&#39; rally\" data-tweet=\"$WDC - WDC cut on &#39;too far&#39; rally https://seekingalpha.com/news/3475197-wdc-cut-on-too-far-rally?source=tweet\" data-url=\"https://seekingalpha.com/news/3475197-wdc-cut-on-too-far-rally\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475196\" data-ts=\"1562066273\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEVA\" target=\"_blank\">TEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475196-teva-up-1-premarket-on-positive-fremanezumab-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teva up 1% premarket on positive fremanezumab data</a></h4><ul><li>Teva Pharmaceutical Industries (NYSE:<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a>) perks up <font color=\"green\">1%</font> premarket on light volume on the heels of <a href=\"https://seekingalpha.com/pr/17561139-teva-presents-positive-results-showing-improvement-disability-quality-life-phase-iiib-focus\" target=\"_blank\">additional data</a> from a Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03308968?titles=focus&amp;lead=teva&amp;rank=1\" target=\"_blank\">FOCUS</a>, evaluating Ajovy (fremanezumab) for the prevention of migraine in adults who failed to respond adequately to two to four classes of preventative treatments. The results were presented at European Academy of Neurology Annual Congress in Oslo.</li><li>Treatment with fremanezumab, a calcitonin gene-related peptide &#40;CGRP&#41; antagonist, reduced the average monthly migraine days and sustained 50+% response rates over three months compared to placebo and reduced the use of acute headache medications.</li><li>Improvements in migraine symptoms (nausea, vomiting, photophobia, phonophobia), quality of life measures, depression and productivity were also noted.</li><li>Complete results will be submitted for publication later this year.</li><li>The FDA approved Ajovy in September 2018. The European Commission approved it in April of this year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475196\" data-linked=\"Teva up 1% premarket on positive fremanezumab data\" data-tweet=\"$TEVA - Teva up 1% premarket on positive fremanezumab data https://seekingalpha.com/news/3475196-teva-up-1-premarket-on-positive-fremanezumab-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3475196-teva-up-1-premarket-on-positive-fremanezumab-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475193\" data-ts=\"1562065853\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RVLV\" target=\"_blank\">RVLV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475193-analyst-coverage-launches-on-revolve-group\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analyst coverage launches on Revolve Group</a></h4><ul> <li>Shares of Revolve Group (NYSE:<a href='https://seekingalpha.com/symbol/RVLV' title='Revolve Group, Inc.'>RVLV</a>) are on watch as analyst coverage comes pouring in after the expiration of the post-IPO quiet period.</li> <li>Bullish ratings are in from Guggenheim (Buy, $50 price target), Morgan Stanley (Overweight, $39 PT), William Blair (Outperform), Cowen (Outperform) and Jefferies (Buy, $60 PT).</li> <li>Barclays (Equalweight, $32 PT) is the only cautious firm with a rating out right now and there are no Sell-equivalent ratings on the books yet.</li> <li>Revolve Group is <font color=\"green\">up 1.71%</font> in premarket trading to $33.35 after the IPO was priced at $18 on June 7.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3475193\" data-linked=\"Analyst coverage launches on Revolve Group\" data-tweet=\"$RVLV - Analyst coverage launches on Revolve Group https://seekingalpha.com/news/3475193-analyst-coverage-launches-on-revolve-group?source=tweet\" data-url=\"https://seekingalpha.com/news/3475193-analyst-coverage-launches-on-revolve-group\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475191\" data-ts=\"1562065381\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BURG\" target=\"_blank\">BURG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475191-hooters-of-america-announces-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hooters of America announces sale</a></h4><ul> <li>Hooters of America announces that Nord Bay Capital and its advisor TriArtisan Capital Advisors have closed on a transaction to acquire the company from H.I.G. Capital, Chanticleer Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/BURG' title='Chanticleer Holdings, Inc.'>BURG</a>) and other investors.</li><li>Financial terms of the deal were not disclosed, although the selling entities will each retain a stake in Hooters.</li> <li>BURG  <font color=\"green\">+11.13%</font> premarket to  $1.16.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17561048-hooters-america-llc-acquired-nord-bay-capital-triartisan-capital-advisors\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3475191\" data-linked=\"Hooters of America announces sale\" data-tweet=\"$BURG - Hooters of America announces sale https://seekingalpha.com/news/3475191-hooters-of-america-announces-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3475191-hooters-of-america-announces-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475189\" data-ts=\"1562065337\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRN\" target=\"_blank\">AMRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475189-amarin-up-8-premarket-on-guidance-boost\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amarin up 8% premarket on guidance boost</a></h4><ul><li>Citing increased demand for Vascepa (icosapent ethyl), Amarin (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRN' title='Amarin Corporation plc'>AMRN</a>) has <a href=\"https://seekingalpha.com/pr/17561220-amarin-provides-midminus-2019-update-including-commercialization-plans-vascepa-updates-full\" target=\"_blank\">raised its 2019 revenue guidance</a> to $380M - 420M from $350M.</li><li>Q2 sales should be $97M - 101M while H1's tally should be $170M - 174M.</li><li>It also plans to double the size of its U.S. salesforce. Recruiting is underway.</li><li>The FDA's action date for its review of the company's supplemental marketing application for a CV benefit claim for Vascepa is September 28.</li><li>Shares are up <font color=\"green\">8%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475189\" data-linked=\"Amarin up 8% premarket on guidance boost\" data-tweet=\"$AMRN - Amarin up 8% premarket on guidance boost https://seekingalpha.com/news/3475189-amarin-up-8-premarket-on-guidance-boost?source=tweet\" data-url=\"https://seekingalpha.com/news/3475189-amarin-up-8-premarket-on-guidance-boost\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>47&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}